APTV Aptiv PLC

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

Aptiv PLC

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

To Our Shareholders

November 6, 2024

Dear Fellow Aptiv Shareholders,

On behalf of our board of directors, we are recommending that Aptiv establish a new publicly listed parent company, Aptiv Holdings Limited (“New Aptiv”), a company that, like Aptiv PLC, will remain incorporated under the laws of Jersey and with the same governance, but which will be resident for tax purposes in Switzerland. We believe this is in the best interests of our shareholders and will provide us with the following benefits:

We believe that the rights of our shareholders will continue to be safeguarded as we maintain our place of incorporation in Jersey and the same corporate governance provisions with New Aptiv. As such, we encourage you to carefully read this Proxy Statement and ask that you vote FOR the proposals described therein.

On behalf of the Board, thank you for your consideration and continued support.

Sincerely,

November 6, 2024

Dear Shareholder:

You are cordially invited to attend two special meetings of the shareholders of Aptiv PLC (“we,” “us,” “our,” “Aptiv PLC,” “Aptiv” or the “Company”) in connection with a proposal to establish a new publicly listed Jersey parent company, Aptiv Holdings Limited (“New Aptiv”), which will be resident for tax purposes in Switzerland.

The establishment of New Aptiv as our new, publicly-listed parent company will be achieved by way of a court-sanctioned scheme of arrangement (the “Scheme”) under Part 18A of the Companies (Jersey) Law 1991 (as amended, modified, or re-enacted from time to time, the “Companies Law”). Approval of the Scheme, which is subject to the satisfaction of certain conditions, will result in the exchange of your shares in Aptiv for shares in New Aptiv on a one-for-one basis. Following the consummation of the Scheme, New Aptiv will be renamed “Aptiv PLC”, and Aptiv will become a wholly owned subsidiary of New Aptiv. We do not expect any material changes in Aptiv’s operations or governance as a result of this transaction. After the completion of the Scheme, we expect shares of New Aptiv will be listed on the New York Stock Exchange under the symbol “APTV,” the same symbol under which Aptiv shares are currently listed, and your rights in shares of New Aptiv will be substantially identical to your current rights in shares of Aptiv.

The first special meeting is a special court-ordered meeting as required by Jersey law (the “Court Meeting”) to vote on the Scheme. The second special meeting is an extraordinary general meeting of shareholders (the “Extraordinary General Meeting” and, together with the Court Meeting, the “Special Meetings”) to approve special resolutions: (i) necessary to implement the Scheme (including, subject to and conditional upon the Scheme becoming effective, to change the name and status of Aptiv); (ii) a merger (the “Merger”) between Aptiv and a wholly-owned subsidiary of New Aptiv, which will occur following the effectiveness of the Scheme and which is described further below. The Court Meeting will be held on December 2, 2024 at 1:00 p.m. (Eastern time), and the Extraordinary General Meeting will be held on December 2, 2024 at 1:15 p.m. (Eastern time), or, if the Court Meeting has not concluded by 1:15 p.m. (Eastern time), as soon as possible after the conclusion of the Court Meeting.

Details of the business to be conducted at the Court Meeting and the Extraordinary General Meeting can be found in the attached Notice of Court Meeting, the attached Notice of Extraordinary General Meeting and the attached Proxy Statement.

After a careful review, our board of directors (the “Board”) has determined that establishing New Aptiv, which will remain organized in Jersey but will be resident for tax purposes in Switzerland, as our new publicly listed parent company is in the best interests of the company and our shareholders. We believe that Swiss tax residency will result in substantial benefits, as further detailed under “Proxy Statement for the Court Meeting and the Extraordinary General Meeting—General Information About the Special Meetings—Why does the Company want to create New Aptiv as its new publicly listed parent company?” in the attached Proxy Statement.

Following the effectiveness of the Scheme and the completion of the share exchange, Aptiv will merge with Aptiv Swiss Holdings Limited (“Aptiv Swiss Holdings” or “Merger Sub”), a newly formed Jersey incorporated private limited company and direct, wholly owned subsidiary of New Aptiv, with Merger Sub surviving the Merger as a direct, wholly owned subsidiary of New Aptiv and Aptiv ceasing to exist. Subject to and conditional upon the Scheme becoming effective, the Board has unanimously approved the Merger on the terms of and subject to the conditions of the merger agreement, dated as of November 4, 2024, by and among Merger Sub and Aptiv (as it may be amended from time to time, the “Merger Agreement”), which contains, among other things, the terms and means of effecting a proposed merger of Aptiv and Merger Sub under Part 18B (Mergers) of the Companies Law, as more fully described elsewhere in this Proxy Statement.

You are being asked to consider and vote on a proposal to approve the Scheme at the Court Meeting. You are also being asked to consider and vote at the Extraordinary General Meeting on (i) a related proposal necessary to implement the Scheme and (ii) a proposal to approve the Merger. The Scheme will be subject to approval by the Royal Court of Jersey (the “Court”). More information about the Scheme and the proposals is

contained in the accompanying Proxy Statement. We urge all Company shareholders to read the accompanying Proxy Statement, including the annexes and the documents incorporated by reference therein, carefully and in their entirety. In particular, we urge you to read carefully “Risk Factors” beginning on page 27 of the accompanying Proxy Statement.

After careful consideration, the Board has (i) approved and declared advisable the Scheme and the Merger, and (ii) declared that it is in the best interests of Company shareholders that Aptiv consummate the Scheme and the Merger. The Board recommends that you vote “FOR” the approval of all proposals presented in the Proxy Statement. Your vote is very important. Please vote as soon as possible, whether or not you plan to attend the Special Meetings, by following the instructions in the accompanying Proxy Statement.

Beneficial Owners

Shareholders who beneficially own Company shares for which Cede & Co. is the registered holder (as nominee for The Depository Trust Company) and whose interests in Company shares are held in “street name” by a broker, bank, trust or other nominee are referred to as “beneficial owners” or “beneficial holders.” If you are a beneficial owner, only your broker, bank, trust or other nominee can vote your Company shares and the vote cannot be cast unless you provide instructions to your broker, bank, trust or other nominee or obtain a legal proxy from your broker, bank, trust or other nominee. You should follow the directions provided by your broker, bank, trust or other nominee regarding how to instruct such person to vote your Company shares. Because the accompanying Proxy Statement relates to two separate Special Meetings, beneficial holders will receive voting instructions applicable to each Special Meeting from their broker, bank, trust or other nominee. Beneficial holders should follow the directions provided by their broker, bank, trust or other nominee regarding how to instruct such broker, bank, trust or nominee to vote their beneficially held shares. Please note that beneficial holders of shares held through a broker, bank, trust or other nominee may be required to submit voting instructions to their applicable broker, bank, trust or nominee at or prior to the deadline applicable for such submission and such holders should, therefore, follow the separate instructions that will be provided by such broker, bank, trust or other nominee.

Shareholders of Record

Shareholders whose names appear in the register of shareholders of Aptiv are referred to as “shareholders of record.” Shareholders of record entitled to vote at each of the Special Meetings may attend the applicable meeting or they may appoint another person or persons, whether a shareholder of Aptiv or not, as their proxy or proxies, to exercise all or any of their rights to attend, speak and vote at the Court Meeting and the Extraordinary General Meeting, as applicable. Shareholders of record are receiving a single mailing that includes forms of proxies with instructions for voting at each of the Court Meeting and the Extraordinary General Meeting. To be valid, each form of proxy should be completed and returned in accordance with the instructions set out on the forms.

Subject to the approvals of the Scheme at the Court Meeting and the related proposal necessary to implement the Scheme at the Extraordinary General Meeting and the satisfaction of the other conditions to the completion of the Scheme, it is anticipated that the Court hearing of the application to sanction the Scheme under Article 125 of the Companies Law (the “Court Hearing”) will take place on December 13, 2024.

Shareholders are entitled to attend and be heard at the Court Hearing, either in person or through a Jersey advocate, to support or oppose the Scheme. The Company will disclose any change in the date of the Court Hearing by public announcement and SEC filing not less than 21 days before the Court Hearing.

This Proxy Statement is dated November 6, 2024, and is first being mailed to shareholders on or about November 8, 2024.

APTIV PLC

5 Hanover Quay,

Grand Canal Dock,

Dublin, Ireland

NOTICE OF COURT MEETING

IN THE MATTER OF APTIV PLC

AND

IN THE MATTER OF ARTICLE 125 OF THE COMPANIES (JERSEY) LAW 1991

NOTICE IS HEREBY GIVEN that, by an Act of the Court dated November 5, 2024 made in the above matters, the Royal Court of Jersey (the “Court”) has ordered a meeting (the “Court Meeting”) to be convened of the holders of the Scheme Shares (as defined in the proposed scheme of arrangement that is included in the accompanying Proxy Statement) of Aptiv PLC (“Aptiv PLC,” “Aptiv” or the “Company”) for the purpose of considering and, if thought fit, approving the following resolution to approve a scheme of arrangement (the “Scheme”) proposed to be made pursuant to Part 18A of the Companies (Jersey) Law 1991, as amended (the “Companies Law”) between Aptiv and the holders of the Scheme Shares, and that the Court Meeting will be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210 on December 2, 2024 at 1:00 p.m. (Eastern time) (unless adjourned or postponed):

“That the Scheme in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Royal Court of Jersey be agreed to.”

A copy of the Scheme and a copy of the explanatory statement required to be published pursuant to Article 126 of the Companies Law are included in the Proxy Statement of which this Notice forms a part. By the said Act of the Court, the Court has appointed Kevin Clark or, failing him, any other director of Aptiv, to act as Chairman of the Court Meeting and has directed the Chairman to report the result thereof to the Court.

Subject to the approval of the resolution proposed at the Court Meeting convened by this Notice, the resolutions to be proposed at the Extraordinary General Meeting of Aptiv convened for December 2, 2024 and the satisfaction of the other conditions to the completion of the Scheme, it is anticipated that the Court Hearing will take place on December 13, 2024. Terms not otherwise defined herein shall have the same meaning in this Notice as they have in the Proxy Statement. The Proxy Statement contains further instructions in relation to the Scheme and the Court Meeting and should be read in its entirety.

The Scheme will be subject to the subsequent sanction of the Court.

Shareholders of Record and Beneficial Holders

Shareholders whose names appear in the register of shareholders of Aptiv are referred to as “shareholders of record.” Shareholders of record as of the Voting Record Time (as defined below) are entitled to attend the Court Meeting or they may appoint another person or persons, whether a shareholder of Aptiv or not, as their proxy or proxies, to exercise all or any of their rights to attend, speak and vote at the Court Meeting.

Shareholders who beneficially own ordinary shares of Aptiv, $0.01 par value per share (“Company Shares”) for which Cede & Co. is the registered holder (as nominee for The Depository Trust Company) and whose interests in Company Shares are held in “street name” by a broker, bank, trust or other nominee are referred to as

“beneficial holders.” Beneficial holders as of the Beneficial Holder Record Time (as defined below) will be entitled to direct their brokers, banks, trusts or other nominees how to vote such beneficially held shares at the Court Meeting. Only a broker, bank, trust or other nominee of a beneficial holder can vote such beneficially held shares and the vote cannot be cast unless such beneficial holder provides instructions to such broker, bank, trust or other nominee, or obtains a legal proxy from such broker, bank, trust or other nominee, which entitles such beneficial holder to vote such shares as a proxy for the shareholder of record.

All shareholders of record and beneficial holders as of the close of business (Eastern time) on October 31, 2024 will receive this Notice.

Right to Appoint a Proxy; Procedure for Appointment

A form of proxy for use at the Court Meeting is being mailed to shareholders of record. To be valid, a form of proxy should be completed and returned in accordance with the instructions set out on the form. A form of proxy duly completed and signed, together with any power of attorney, if any, under which it is signed, should be returned in accordance with the instructions set out in the form as promptly as possible and no later than 11:59 p.m. (Eastern time) on November 29, 2024.

If the form of proxy for use at the Court Meeting is not returned by the above time, it may be handed to Aptiv’s Registrars (on behalf of the Chair of the Court Meeting) or to the Chair of the Court Meeting before the start of the Court Meeting and it will be valid. However, in the case of the Extraordinary General Meeting, unless the form of proxy for use at the Extraordinary General Meeting is returned by the time noted above, it will be invalid.

Completion and return of a form of proxy will not preclude a shareholder of record as of the Voting Record Time from attending the Court Meeting, or any adjournment or postponement thereof, if that shareholder wishes and is entitled to do so.

Beneficial holders will receive voting instructions from their broker, bank, trust or other nominee for the Court Meeting. Beneficial holders should follow the directions provided by their broker, bank, trust or other nominee regarding how to instruct such broker, bank, trust or nominee to vote their beneficially held shares. Please note that beneficial holders of shares through a broker, bank, trust or other nominee may be required to submit voting instructions to their applicable broker, bank, trust or nominee at or prior to the deadline applicable for such submission and such holders should, therefore, follow the separate instructions that will be provided by such broker, bank, trust or other nominee.

If the form of proxy is properly executed and returned, it will be voted in the manner directed by the shareholder executing it, or if no directions are given, it will be voted at the discretion of the individuals referred to on the form of proxy or any other person duly appointed as proxy by the shareholder.

In the case of a corporation, the form of proxy must be signed by a duly authorized officer, giving full title as such.

Voting Record Time

Shareholders of record entitled to attend and vote at the Court Meeting, or any adjournment or postponement thereof, and the number of votes which may be cast, will be determined by reference to the register of shareholders of Aptiv as of 6:00 p.m. (Jersey time) on November 27, 2024 or at 6:00 p.m. (Jersey time) on the date which is two business days prior to any adjournment or postponement of the Court Meeting (as the case may be) (the “Voting Record Time”).

Beneficial Holder Record Time

Only beneficial holders as of the close of business (Eastern time) on October 31, 2024 (the “Beneficial Holder Record Time”) will be entitled to direct their brokers, banks, trusts or other nominees how to vote such beneficially held shares at the Court Meeting.

Joint Holders

In the case of joint holders of Company Shares that are shareholders of record, the vote of the senior holder who tenders a vote (in person or by proxy) will be accepted to the exclusion of the vote(s) of the other joint holder(s). For this purpose, seniority will be determined by the order in which the names of the holders stand in the register of shareholders of Aptiv in respect of such joint holding.

Issued Shares and Total Voting Rights

As of October 31, 2024, the total number of issued and outstanding Company Shares entitled to vote at the Court Meeting is 235,035,739. The proposal to approve the Scheme at the Court Meeting shall be decided on a poll. Every holder of a Company share that is entitled to vote (in person or by proxy) will have one vote for every Company share carrying voting rights of which he, she or it is the holder. The Scheme proposal must be approved by (a) a majority in number of shareholders of record as of the Voting Record Time that are present and voting (in person or by proxy) at the Court Meeting and (b) at least 75% of the votes cast by the Company shareholders present and voting (in person or by proxy).

YOUR VOTE IS IMPORTANT

SHAREHOLDERS OF RECORD ARE RECEIVING A SINGLE MAILING THAT INCLUDES FORMS OF PROXIES WITH INSTRUCTIONS FOR VOTING AT EACH OF THE COURT MEETING AND THE EXTRAORDINARY GENERAL MEETING. YOU ARE ENCOURAGED TO VOTE AT EACH SPECIAL MEETING. IT IS IMPORTANT THAT AS MANY VOTES AS POSSIBLE ARE CAST AT THE COURT MEETING (IN PERSON OR BY PROXY) SO THAT THE COURT CAN BE SATISFIED THAT THERE IS A FAIR AND REASONABLE REPRESENTATION OF COMPANY SHAREHOLDER OPINION. TO ENSURE YOUR REPRESENTATION AT THE COURT MEETING, YOU ARE REQUESTED TO COMPLETE, SIGN AND DATE THE FORM OF PROXY FOR THE COURT MEETING AS PROMPTLY AS POSSIBLE AND RETURN IT IN THE POSTAGE PREPAID ENVELOPE ENCLOSED FOR THAT PURPOSE OR VOTE BY TELEPHONE OR OVER THE INTERNET FOLLOWING THE INSTRUCTIONS PROVIDED IN THE FORM OF PROXY. IF YOU ARE A SHAREHOLDER OF RECORD AND ATTEND THE COURT MEETING, YOU MAY VOTE DURING THE COURT MEETING EVEN IF YOU HAVE RETURNED A COMPLETED FORM OF PROXY. BENEFICIAL HOLDERS WILL RECEIVE VOTING INSTRUCTIONS APPLICABLE TO EACH SPECIAL MEETING FROM THEIR BROKER, BANK, TRUST OR OTHER NOMINEE. BENEFICIAL HOLDERS SHOULD FOLLOW THE DIRECTIONS PROVIDED BY THEIR BROKER, BANK, TRUST OR OTHER NOMINEE REGARDING HOW TO INSTRUCT SUCH BROKER, BANK, TRUST OR NOMINEE TO VOTE THEIR BENEFICIALLY HELD SHARES.

Dated November 6, 2024

Carey Olsen Jersey LLP

47 Esplanade,

St Helier, Jersey, JE1 0BD

Solicitors for Aptiv

APTIV PLC

5 Hanover Quay,

Grand Canal Dock,

Dublin, Ireland

NOTICE OF EXTRAORDINARY GENERAL MEETING OF APTIV PLC

NOTICE IS HEREBY GIVEN that an EXTRAORDINARY GENERAL MEETING (the “Extraordinary General Meeting”) of Aptiv PLC (“Aptiv PLC,” “Aptiv” or the “Company”) will be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210 on December 2, 2024 at 1:15 p.m. (Eastern time) or, if the Court Meeting (as defined in the scheme of arrangement that is included in the accompanying Proxy Statement of which this Notice forms a part (the “Scheme”)) has not concluded by 1:15 p.m. (Eastern time), as soon as possible after the conclusion of the Court Meeting for the purpose of considering and, if thought fit, passing the following resolutions.

SPECIAL RESOLUTIONS

1. THAT for the purpose of giving effect to the Scheme, in its original form or subject to such modification, addition or condition approved or imposed by the Royal Court of Jersey (the “Court”) and agreed by Aptiv and Aptiv Holdings Limited (“New Aptiv”):

(a) the directors of Aptiv (or a duly authorized committee thereof) be authorized to take all such action as they may consider necessary or appropriate for carrying the Scheme into full effect;

(b) with effect from the passing of this resolution, the Articles of Association of Aptiv be and are hereby amended by the adoption and inclusion of the following new Article 41:

“41 SCHEME OF ARRANGEMENT

41.1 In this Article 41:

(a) New Aptiv means Aptiv Holdings Limited, a Jersey public company with company number 156354; and

(b) the Scheme means the scheme of arrangement dated November 6 2024 between the Company and the Scheme Shareholders (as defined in the Scheme) under Article 125 of the Companies Law in its original form or with or subject to any modification, addition or condition approved or imposed by the Royal Court of Jersey and agreed by the Company and New Aptiv and (save as defined in this Article) expressions defined in the Scheme shall have the same meanings in this Article.

41.2 Notwithstanding any other provision of these Articles or the terms of any resolution passed by the Company in the Extraordinary General Meeting, if the Company issues any shares (other than to New Aptiv or its nominee) on or after the Voting Record Time and at or prior to the Scheme Record Time, such shares shall be issued subject to the terms of the Scheme (and shall be Scheme Shares for purposes thereof) and the original or any subsequent holder or holders of such shares shall be bound by the Scheme accordingly.

41.3 Subject to the Scheme becoming effective, and notwithstanding any other provision of these Articles, if any shares are issued, transferred out of treasury or transferred to any person (other than New Aptiv or its nominee) (the “New Member”) after the Scheme Record Time (the “Post-Scheme Shares”), such New Member shall be obliged to transfer forthwith the Post-Scheme Shares, free from encumbrances, held by the New Member (or any subsequent holder of any nominee of such New Member or any such subsequent holder), to New Aptiv (or as New Aptiv may direct) who shall be obliged to acquire each Post-Scheme Share in exchange for the issue or transfer to the relevant allottees of one New Aptiv Share for every one Post-Scheme Shares transferred (provided that any fraction of a New Aptiv Share shall be disregarded) as if each such Post-Scheme Share had been a Scheme Share. The New Aptiv Shares issued or transferred pursuant to this Article 41.3 to the New Member will be credited as fully paid and will rank equally in all respects with all New Aptiv Shares in issue at the time and be subject to the articles of association of New Aptiv.

41.4 On any reorganization of, or material alteration to, the share capital of the Company (including, without limitation, any subdivision and/or consolidation), the number of New Aptiv Shares to be issued or transferred under Article 41.3 may be adjusted by the Directors in such manner as the auditors of the Company or an investment bank selected by the Company may determine to be appropriate to reflect such reorganization or alteration, provided always that any fractions of New Aptiv Shares shall be disregarded. References in this Article 41 to shares or New Aptiv Shares shall, following such adjustment, be construed accordingly.

41.5 To give effect to any transfer required by this Article, the Company may appoint (and each New Member hereby accepts the appointment of) any person as the Company may determine as attorney under the Powers of Attorney (Jersey) Law 1995 and any such appointment shall be irrevocable for a period of one year from the date upon which such New Member is issued the relevant Post-Scheme Shares for that New Member) and/or agent for the New Member to execute and deliver as transferor a form of transfer or instructions of transfer on behalf of the New Member (or any subsequent holder or any nominee of such New Member or any such subsequent holder) in favor of New Aptiv or its nominee and do all such other things and execute and deliver all such documents as may in the opinion of the Attorney be necessary or desirable to vest the Post-Scheme Shares in New Aptiv or its nominee and pending such vesting to exercise all such rights to the Post-Scheme Shares as New Aptiv may direct. If an Attorney is so appointed, the New Member shall not thereafter be entitled to exercise any rights attaching to the Post-Scheme Shares unless so agreed by New Aptiv. The Company may give good receipt for the consideration for the Post-Scheme Shares and may register New Aptiv or its nominee as holder thereof and issue to it certificate(s) for the same. The Company shall not be obliged to issue a certificate to the New Member for any Post-Scheme Shares.

41.6 If the Scheme shall not have become effective by the date referred to in clause 6(b) of the Scheme (or such later date, if any, as New Aptiv and the Company may agree and the Jersey Court may allow), this Article 41 shall be of no effect.

41.8 Notwithstanding any other provision of these Articles, the Directors may refuse to register the transfer of any Scheme Shares effected between the Scheme Record Time and the date on which the Scheme becomes effective (the “Effective Date”) other than to New Aptiv and/or its nominees pursuant to the Scheme or this Article.

41.9 Notwithstanding any other provision of these Articles, the Directors may refuse to register the transfer of any shares other than pursuant to the Scheme or as provided by this Article, but neither the Company nor the directors of the Company may refuse to register the transfer of any shares pursuant to the Scheme or as provided by this Article.”

(c) subject to and conditional upon the Scheme becoming effective, the name of the Company be changed to “Aptiv Irish Holdings Limited” and that, with effect as at the time such change of name becomes effective pursuant to the Companies (Jersey) Law 1991 (the “Companies Law”), all references in the memorandum and articles of association of the Company to the existing name of the Company be changed to such new name.

(d) subject to and conditional upon the Scheme becoming effective, pursuant to Article 16 of the Companies Law the Company changes its status to become a private company and in connection therewith the memorandum of association of the Company be and is hereby altered by the deletion of paragraph 3.1 and the insertion in its place of a new paragraph 3.1 as follows:

“3.1 The Company is a private company.”

2. THAT subject to and conditional upon the Scheme becoming effective, the form of merger agreement that it is proposed be entered into between the Company and Aptiv Swiss Holdings Limited (the “Merger Agreement”) and that states, among other things, the terms and means of effecting a proposed merger of those parties under Article 18B (Mergers) of the Companies (Jersey) Law 1991 (the “Companies Law”) be hereby approved for all purposes, including (without limitation) for the purposes of Article 127F(1) of the Companies Law; and the directors of Aptiv PLC (or a duly authorized committee thereof) be and are authorized to take all such action as they may consider necessary or desirable for the implementation of the Merger pursuant to the terms and subject to the conditions contained in the Merger Agreement.

Holders of shares in Aptiv entitled to vote at the Extraordinary General Meeting may attend the Extraordinary General Meeting and vote during the meeting or they may appoint another person or persons, whether a shareholder of Aptiv or not, as their proxy or proxies, to exercise all or any of their rights to attend, speak and vote at the Extraordinary General Meeting. Further instructions as to how to attend and vote at the Extraordinary General Meeting and appoint proxies and further information on the proposals, voting and quorum requirements are set out in the accompanying Proxy Statement of which this notice forms a part.

5 Hanover Quay, Dublin 2, Ireland D02 VY79

November 6, 2024

TABLE OF CONTENTS

i

ii

APTIV PLC

PROXY STATEMENT

FOR

THE COURT MEETING AND THE EXTRAORDINARY GENERAL MEETING

These proxy materials are provided in connection with the solicitation of proxies by the board of directors of Aptiv PLC (the “Board”), a company organized under the laws of Jersey, for the court-ordered meeting (“the Court Meeting”) to be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210 on December 2, 2024 at 1:00 p.m. (Eastern time) (unless adjourned or postponed) and the extraordinary general meeting (the “Extraordinary General Meeting” and, together with the Court Meeting, the “Special Meetings”) to be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210 on December 2, 2024 at 1:15 p.m. (Eastern time) (unless adjourned or postponed) or, if the Court Meeting has not concluded by 1:15 p.m. (Eastern time), as soon as possible after the conclusion of the Court Meeting.

General Information About the Special Meetings

General

This Proxy Statement has information about the Court Meeting and the Extraordinary General Meeting and was prepared by our management for the Board. This Proxy Statement is being mailed through the U.S. postal service to shareholders on or around November 8, 2024.

In this Proxy Statement, we sometimes refer to Aptiv PLC before the Transaction (as defined below) and New Aptiv (as defined below) after the Transaction as “we,” “us,” “our,” “Aptiv” or the “Company” as the context may require.

Purpose of the Special Meetings

The specific proposals to be considered and acted upon at the Court Meeting and the Extraordinary General Meeting are summarized in the accompanying Notice of Court Meeting and Notice of Extraordinary General Meeting respectively and described in more detail in this Proxy Statement. See in particular “—Information about the Reorganization” below.

Why am I receiving this Proxy Statement?

It is proposed that Aptiv Holdings Limited (“New Aptiv”), a company that, like Aptiv PLC, will remain organized under the laws of Jersey but will be resident for tax purposes in Switzerland, become our new publicly listed parent company. See “—Information about the Reorganization” below for further details.

It is intended that this be implemented by means of a court-sanctioned scheme of arrangement (the “Scheme”) between Aptiv and the Scheme Shareholders (as defined in “Part 3—The Scheme of Arrangement”), under Part 18A of the Companies (Jersey) Law 1991 (the “Companies Law”), pursuant to which all ordinary shares, par value $0.01 per share, of Aptiv PLC (the “shares” or “Company Shares”) will be exchanged for ordinary shares, par value $0.01 per share, of New Aptiv (the “New Aptiv Shares”), a new holding company incorporated under the laws of Jersey and resident for tax purposes in Switzerland, on a one-for-one basis, such that the holders of Company Shares will become shareholders of New Aptiv, and Aptiv PLC will become a wholly owned subsidiary of New Aptiv (collectively, the “Transaction”). After the consummation of the Scheme, New Aptiv will be renamed “Aptiv PLC,” and we expect the New Aptiv Shares will be listed on the New York Stock Exchange under the symbol “APTV,” the same symbol under which Company Shares are currently listed.

Following the consummation of the Transaction, it is proposed that Aptiv PLC will merge (the “Merger”) with Aptiv Swiss Holdings Limited (“Aptiv Swiss Holdings” or “Merger Sub”), a newly formed Jersey-incorporated private limited company and direct, wholly owned subsidiary of New Aptiv, with Merger Sub surviving the Merger as a direct, wholly owned subsidiary of New Aptiv and Aptiv PLC ceasing to exist.

1

The Royal Court of Jersey (the “Court”) has ordered the convening of the Court Meeting in order to obtain shareholder approval of the Scheme. Following the Court Meeting, the Company will hold the Extraordinary General Meeting in order to obtain shareholder approval of a related proposal necessary to implement the Scheme and a proposal to approve the Merger.

It will not be possible to complete the Transaction and the Merger unless the requisite Company shareholder approvals described below are obtained at each Special Meeting.

We have included in this Proxy Statement important information about the Transaction, the Merger and the Special Meetings. You should read this information carefully and in its entirety. If you are a shareholder whose name appears in the register of shareholders of Aptiv (a “shareholder of record”), you are receiving a single mailing that includes forms of proxies with instructions for voting at each of the Court Meeting and the Extraordinary General Meeting. You may vote your Company Shares without attending the applicable Special Meeting by granting a proxy or voting your Company Shares by mail, telephone or over the internet following the instructions provided in the applicable form of proxy. If you hold your shares through a broker, bank, trust or other nominee, you should follow the instructions provided by your broker, bank, trust or other nominee in order to instruct them how to vote such shares.

Why are there two Special Meetings?

At the Court Meeting, Company shareholders will be asked to approve the Scheme for purposes of satisfying Jersey legislation requirements.

At the Extraordinary General Meeting, Company shareholders will also be asked to (a) authorize the directors of the Board to take all actions as they consider necessary or appropriate for carrying the Scheme into effect and to amend the Company’s articles of association in order to implement to the Scheme; and (b) approve the Merger. For more details on these matters, see “Part 2—Explanatory Statement—4. Court Meeting and Extraordinary General Meeting.”

Both Special Meetings are necessary to cause the Scheme to become effective.

When and where will each Special Meeting be held?

The Court Meeting will be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210 on December 2, 2024 at 1:00 p.m. (Eastern time) (unless adjourned or postponed). The Extraordinary General Meeting will be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210 on December 2, 2024 at 1:15 p.m. (Eastern time) (unless adjourned or postponed) or, if the Court Meeting has not concluded by 1:15 p.m. (Eastern time), as soon as possible after the conclusion of the Court Meeting.

Who can vote?

Shareholders of record as of 6:00 p.m. (Jersey time) on November 27, 2024 or 6:00 p.m. (Jersey time) on the date which is two business days prior to any adjournment or postponement of the Court Meeting (as the case may be) (the “Voting Record Time”) are entitled to attend the Special Meetings and vote at the Special Meetings or they may appoint another person or persons, whether a Company shareholder or not, as their proxy or proxies, to exercise all or any of their rights to attend, speak and vote at the Special Meetings.

Shareholders who beneficially own Company Shares for which Cede & Co. is the registered holder (as nominee for The Depository Trust Company) and whose interests in Company Shares are held in “street name” by a broker, bank, trust or other nominee (“beneficial owners” or “beneficial holders”) as of the close of business (Eastern time) on October 31, 2024 (the “Beneficial Holder Record Time”) will be entitled to direct their broker, bank, trust or other nominee how to vote such beneficially held shares at the Special Meetings.

2

How do I vote?

If you are a shareholder of record, you will receive two forms of proxy (one for the Court Meeting and one for the Extraordinary General Meeting). You may vote your Company Shares at each Special Meeting in one of the following ways:

If you hold your Company Shares through a broker, bank, trust or other nominee, you should follow the instructions provided by your broker, bank, trust or other nominee in order to instruct them how to vote your Company Shares.

In the case of joint holders, the vote of the senior member who tenders a vote (in person via or by proxy) will be accepted to the exclusion of the votes of the other joint holders of record and, for this purpose, seniority will be determined by the order in which the names first appear in the Company’s register of members in respect of the joint holding.

If my shares are held in “street name” by my broker, bank, trust or other nominee, will my broker, bank, trust or other nominee automatically vote my shares for me?

No. Your broker, bank, trust or other nominee will not vote your Company Shares if you do not provide your broker, bank, trust or other nominee with a signed voting instruction form with respect to your Company Shares, such failure to vote being referred to as a broker non-vote. Therefore, you should instruct your broker, bank, trust or other nominee to vote your Company Shares by following the directions your broker, bank, trust or other nominee provides.

Brokers do not have discretionary authority to vote on any of the proposals at either Special Meeting.

How many votes do I have?

At each Special Meeting, you are entitled to one vote for each Company Share that you owned as of the Beneficial Holder Record Time, if you are a beneficial holder, or as of the Voting Record Time, if you are a shareholder of record. Each beneficial owner of Company Shares as of the Beneficial Holder Record Time will be entitled to direct his or her broker, bank, trust or other nominee how to vote such Company Shares on all resolutions proposed at the Court Meeting and the Extraordinary General Meeting. As of the Beneficial Holder Record Time, there were 235,035,739 Company Shares outstanding and entitled to vote at each of the Court Meeting and the Extraordinary General Meeting.

May I vote in person at the Special Meetings?

Although we encourage you to complete and return the proxy cards to ensure that your vote is counted, you may attend the Special Meetings and vote your shares in person. If you are a holder of record whose shares are registered in your name and you wish to vote at the Special Meetings, written ballots will be available at each Special Meeting. If you are a beneficial holder whose shares are held in the name of a bank, broker, trustee, custodian or other nominee and you decide to attend and vote at the Special Meetings, you will need to obtain a proxy, executed in your favor, from the holder of record to be able to vote at the applicable Special Meeting. If you vote by proxy and also attend a Special Meeting, there is no need to vote again at the applicable Special Meeting unless you wish to change your vote. Note that if you plan to attend the Special Meetings in person, you must register in advance and present the necessary identification.

3

What am I being asked to vote on?

Company shareholders are being asked to vote on one proposal related to the Scheme at the Court Meeting, and one proposal related to the Scheme and one proposal related to the Merger at the Extraordinary General Meeting. However, the vote required to approve each such proposal is different at each of the Special Meetings.

The Transaction is conditioned on the approval of the Scheme at the Court Meeting (the “Scheme Proposal”). As set out in full under the section entitled “Part 2—Explanatory Statement” beginning on page 68, the Scheme Proposal must be approved by (a) a majority in number of the Company shareholders of record as of the Voting Record Time that are present and voting (in person or by proxy) at the Court Meeting and (b) at least 75% of the votes cast by the Company shareholders present and voting (in person or by proxy).

The vote required to approve the Scheme Proposal at the Court Meeting is based on votes properly cast at the meeting by shareholders of record. Broker non-votes (as defined below) are not considered votes properly cast and will have no effect on such proposal. In accordance with Jersey law, abstentions are not permitted with respect to the Scheme Proposal.

The following resolutions are proposed to be voted on at the Extraordinary General Meeting:

Special Resolutions:

At the Extraordinary General Meeting, the requisite shareholder approval of each of the resolutions depends on whether it is an “ordinary resolution”, which requires the approval of at least a majority of the votes cast by Company shareholders present and voting (in person or by proxy), or a “special resolution”, which requires the approval of at least two-thirds (2/3) of the votes cast by Company shareholders present and voting (in person or by proxy). The Company Shareholder Proposals are “special resolutions” requiring approval of at least two-thirds (2/3) of the votes cast by Company shareholders present and voting (in person or by proxy) at the Extraordinary General Meeting. The votes required to approve the Company Shareholder Proposals are based on Company shareholder votes properly cast at the Extraordinary General Meeting. Abstentions and broker non-votes will be counted for purposes of determining a quorum but not for purposes of determining the number of votes properly cast. As a result, abstentions and broker non-votes will have no effect on the Company Shareholder Proposals.

As of October 28, 2024, the Company directors and executive officers had the right to vote less than one percent of the Company Shares then outstanding and entitled to vote at the Court Meeting and the Extraordinary

4

General Meeting. It is expected that the Company’s directors and executive officers will vote “FOR” each of the proposals at the Court Meeting and the Extraordinary General Meeting, although none of them have entered into any agreement or instrument requiring them to do so.

Your vote is very important. It is important that as many votes as possible are cast, so that the Court may be satisfied that there is a fair and reasonable representation of the opinion of the Company shareholders. Shareholders of record are receiving a single mailing that includes forms of proxies with instructions for voting at each of the Court Meeting and the Extraordinary General Meeting. You are encouraged to submit a form of proxy (or vote by telephone or over the internet following the instructions in the form of proxy) for each of the Court Meeting and the Extraordinary General Meeting as soon as possible. Beneficial holders will receive voting instructions applicable to each Special Meeting from their broker, bank, trust or other nominee. Beneficial holders should follow the directions provided by their broker, bank, trust or other nominee regarding how to instruct such broker, bank, trust or nominee to vote their beneficially held shares. The Board recommends that you vote “FOR” each of the proposals at the Court Meeting and the Extraordinary General Meeting.

Why are there different record times for shareholders of record and beneficial owners of Company Shares?

As described in response to the question titled “What am I being asked to vote on?” above, in addition to the Scheme Proposal being approved by at least 75% of the votes cast at the Court Meeting by the Company shareholders present and voting (in person or by proxy), the Scheme Proposal must also be approved by a majority in number of the Company shareholders as of the Voting Record Time that are present and voting (in person or by proxy) at the Court Meeting. Under Jersey law, only shareholders of record are counted in the number of holders entitled to vote and who are present for purposes of the voting requirements.

The Company established the close of business (Eastern time) on October 31, 2024, as the Beneficial Holder Record Time in order to provide (i) all Company shareholders, including beneficial owners of Company Shares, with sufficient notice of the Court Meeting and the Extraordinary General Meeting and (ii) Cede & Co. (as nominee for The Depository Trust Company) and brokers, banks, trusts or other nominees with sufficient time to obtain voting instructions from beneficial owners.

However, in order to determine the final number of shareholders of record on the Company’s share register maintained by Computershare for purposes of the voting requirements described above, the Company has established 6:00 p.m. (Jersey time) on November 27, 2024, as the Voting Record Time.

How does the Board recommend that I vote on the proposals?

The Board recommends that Company shareholders vote:

The Board’s recommendation that Company shareholders vote in favor of the Scheme Proposal, the Scheme and Articles Amendment Proposal and the Merger Proposal are referred to as the “Board Recommendation.”

What if other matters come up at the Special Meetings?

The matters described in this Proxy Statement are the only matters that we know will be voted on at the Special Meetings. Matters other than those matters discussed in this Proxy Statement may not be presented at the Special Meetings.

5

May I revoke my proxy?

If you are a shareholder of record, you may revoke your proxy before it is voted at the Court Meeting or before your proxy is voted at the Extraordinary General Meeting by:

If you are a beneficial holder with shares held in “street name” by a broker, bank, trust or other nominee, you should follow the instructions of your broker, bank, trust or other nominee regarding the revocation of proxies.

How many votes must be present to hold the Special Meetings?

A “quorum” must be present for either Special Meeting to be held. A “quorum” for the Court Meeting is 2 Scheme Shareholders present in person or by proxy as the Chair may determine. Pursuant to the Memorandum and Articles of Association of the Company, a “quorum” for the Extraordinary General Meeting is at least one (1) or more persons present in person and collectively representing, in person or by proxy, more than 50% of the total issued Company Shares. If a quorum is not present, the applicable Special Meeting may be adjourned from time to time until a quorum is obtained.

How are votes counted?

Company Shares represented in person or by proxy, including shares which abstain or do not vote with respect to one or more of the matters presented for shareholder approval, will be counted for purposes of determining whether a quorum is present. The shares of beneficial holders whose shares are held in the name of a nominee, and who do not tell the nominee how to vote their shares, will be counted for purposes of determining the presence or absence of a quorum for the transaction of business. However, abstentions and broker non-votes are not counted in the tally of votes FOR or AGAINST a proposal. A WITHHELD vote is the same as an abstention.

Will my shares be voted if I do not provide my proxy?

Your shares may be voted if you hold them “beneficially,” even if you do not provide the brokerage firm with voting instructions. Brokerage firms have the authority, under applicable regulatory requirements, to vote shares for which their customers do not provide voting instructions on certain “routine” matters.

The approval of the Scheme is not considered a routine matter for which brokerage firms may vote unvoted shares. Approval of the proposal to adjourn the Special Meetings to a later date to solicit additional proxies if there are insufficient proxies to approve the Scheme at the time of the meeting is considered a routine matter for which brokerage firms may vote unvoted shares.

What does it mean if I receive more than one proxy card?

You should receive one proxy card for each Special Meeting. If you receive more than one card for either meeting, it means that you have multiple accounts with brokers or Computershare, the Company’s transfer agent

6

(the “Transfer Agent”). Please vote all of these shares. The Company encourages you to have all your shares registered in the same name and address. You may do this by contacting your broker or the Transfer Agent.

Who is making and paying for this proxy solicitation?

We will pay the cost for soliciting proxies for the Special Meetings. Aptiv will distribute proxy materials and follow-up reminders by mail and electronic means. We have engaged Innisfree M&A Incorporated (“Innisfree”) to assist with the solicitation of proxies. We expect to pay Innisfree an aggregate fee, including reasonable out-of-pocket expenses, of $45,000, depending on the level of services actually provided. Certain Aptiv employees, officers and directors may also solicit proxies by mail, telephone or personal visits but they will not receive any additional compensation for their services.

We will also reimburse brokers, banks and other nominees for their expenses in forwarding proxy materials to beneficial owners.

What do I need to do now?

Company shareholders entitled to vote at the Court Meeting have been sent a form of proxy for that meeting, and Company shareholders entitled to vote at the Extraordinary General Meeting have been separately sent a form of proxy for that meeting. Company shareholders are strongly urged to complete and return both forms of proxy as soon as possible and, in any event, no later than 11:59 p.m. (Eastern time) on November 29, 2024.

If the form of proxy for use at the Court Meeting is not returned by the above time, it may be handed to Aptiv’s Registrars (on behalf of the Chair of the Court Meeting) or to the Chair of the Court Meeting before the start of the Court Meeting and it will be valid. However, in the case of the Extraordinary General Meeting, unless the form of proxy for use at the Extraordinary General Meeting is returned by the time noted above, it will be invalid.

Even if you plan to attend either or both Special Meetings, we encourage you to vote by proxy before the Special Meeting(s) that you plan to attend. After carefully reading and considering the information contained in this Proxy Statement, including the annexes and the documents incorporated by reference, please submit your proxy or proxies by telephone or over the internet in accordance with the instructions set forth on the applicable form of proxy, or mark, sign and date the applicable form of proxy and return it with the enclosed prepaid envelope as soon as possible so that your Company Shares may be voted at the applicable Special Meeting. Your form of proxy or your telephone or internet directions will instruct the persons identified as your proxy to vote your Company Shares at the applicable Special Meeting as directed by you.

If a Company shareholder signs and returns his, her or its form of proxy appointing the individuals referred to on the form of proxy of the applicable Special Meeting as his, her or its proxy but does not mark the form of proxy to tell the proxy how to vote on a proposal, such shares will be voted in respect of such proposal at the discretion of the named proxies of the applicable Special Meeting.

If you hold your Company Shares through a broker, bank, trust or other nominee, you should follow the instructions provided by your broker, bank, trust or other nominee when instructing them how to vote your Company Shares.

May I attend the Court Hearing to sanction the Scheme?

Company shareholders are entitled to attend and be heard at the hearing of the Court to sanction the Scheme (the “Court Hearing”), either in person or through a Jersey advocate, to support or oppose the Scheme. The Court’s address is Royal Court House, Royal Square, St Helier, Jersey JE1 1JG and its telephone number is +44 1534 441 300. It is anticipated that the Court Hearing will take place on December 13, 2024. The Company will disclose any change in the date of the Court Hearing by public announcement and filing with the Securities and Exchange Commission (the “SEC”) no later than 21 days before the Court Hearing.

7

May I change my vote after I have mailed my signed forms of proxy or voted by telephone or over the internet?

Yes, you may change your vote before your proxy is voted at the Court Meeting or before your proxy is voted at the Extraordinary General Meeting.

If you are a shareholder of record, you can do this in one of four ways:

If you are a beneficial holder and have instructed a broker, bank, trust or other nominee to vote your shares, you must follow directions received from your broker, bank, trust or other nominee to change your vote or revoke your proxy.

Information About the Reorganization

Why does the Company want to establish New Aptiv as its new publicly listed parent company?

Our board of directors has determined that it is in the best interests of Aptiv and its shareholders to establish New Aptiv as our new publicly listed parent company, which will remain organized in Jersey but will be resident for tax purposes in Switzerland, and that doing so would result in substantial benefits, including the following:

We believe that our publicly listed parent company should remain organized in Jersey given the flexible nature of Jersey corporate law. We believe that it is in the best interests of Aptiv and its shareholders to establish a new parent company, New Aptiv, rather than to undertake another form of transaction.

We cannot assure you that the anticipated benefits of the Reorganization will be realized. In addition to the potential benefits described above, the Reorganization will expose you and us to some risks. These risks include

8

the following: the market for the New Aptiv Shares may differ from the market for Company Shares; the Reorganization may not allow us to maintain a competitive worldwide effective corporate tax rate; legislative and regulatory action could materially and adversely affect us; we will be subject to various Swiss taxes as a result of the Reorganization; if the Court does not approve the Scheme, Aptiv PLC will not have the ability to effect the Reorganization; following the completion of the Reorganization, it is possible that we will be removed from the S&P 500 stock index and other indices, which could have an adverse impact on our share price; the Reorganization will result in additional direct and indirect costs, even if the Reorganization is not completed; and we may choose to abandon or delay the Transaction. Please see the discussion under “Risk Factors.” Our Board has considered both the potential advantages of the Reorganization and these risks and has unanimously approved the Scheme and recommended that the shareholders vote for the Scheme.

Will the Reorganization affect Aptiv PLC’s current or future operations?

We believe that the Reorganization will have no material impact on how we conduct our day-to-day operations. The location of our future operations will depend on the needs of our business, independent of our tax residence.

How will the Reorganization affect our presence in the United States and Ireland?

There are no changes planned for our U.S. or Irish operations or workforce as a result of the Reorganization.

What will be Aptiv’s corporate presence in Switzerland?

In connection with the Reorganization, we have established an office in Switzerland, relocated certain employees to Switzerland and have hired additional employees in Switzerland.

Will the Transaction dilute my economic interest in Aptiv PLC?

No. Your relative economic ownership in Aptiv PLC will not change as a result of the Transaction.

How will the Reorganization affect financial reporting?

After the Reorganization, New Aptiv will continue to prepare financial statements in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) and report in U.S. dollars and will continue to file reports on Forms 10-K, 10-Q and 8-K with the SEC, as Aptiv PLC currently does.

What impact will the Reorganization have on Aptiv’s current debt arrangements?

There will be no material impact on our debt arrangements. In connection with the Reorganization, immediately following the effectiveness of the Transaction, Aptiv PLC will merge with and into Merger Sub, a wholly owned subsidiary of New Aptiv, with Merger Sub surviving, under Part 18B (Mergers) of the Companies Law, as more fully described elsewhere in this Proxy Statement. In connection with the Merger, Merger Sub will (i) enter into (a) a supplemental indenture to the Senior Notes Indenture dated March 10, 2015, as amended from time to time (the “Senior Notes Indenture”), among Aptiv PLC, the guarantors party thereto and Wilmington Trust, National Association, as trustee, pursuant to which Merger Sub assume all of Aptiv PLC’s obligations under each series of Aptiv PLC’s outstanding senior unsecured notes (the “Senior Unsecured Notes”) issued under the Senior Notes Indenture and (b) a supplemental indenture to the Subordinated Indenture dated September 13, 2024, as amended from time to time (the “Subordinated Notes Indenture” and, together with the Senior Notes Indenture, each, an “Indenture” and together, the “Indentures”), among Aptiv PLC, the guarantors party thereto and Wilmington Trust, National Association, as trustee, pursuant to which Merger Sub will assume all of Aptiv PLC’s obligations under Aptiv PLC’s outstanding junior subordinated notes (the “Subordinated Notes” and, together with the Senior Unsecured Notes, the “Notes”) issued under the Subordinated Notes

9

Indenture and (ii) enter into (a) an assumption and/or supplement agreement relating to each of (a) the Third Amended and Restated Credit Agreement, dated as of June 24, 2021, as amended from time to time (the “Revolving Facility Credit Agreement”), among Aptiv PLC, Aptiv Corporation, Aptiv Global Financing Designated Activity Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto, and (b) the Term Credit Agreement, dated August 19, 2024, as amended from time to time (the “Term Loan A Credit Agreement” and, together with the Revolving Facility Credit Agreement, each, a “Credit Agreement” and together, the “Credit Agreements”), among Aptiv PLC and certain of its subsidiaries, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto, in each case pursuant to which New Aptiv will assume all of Aptiv PLC’s obligations under the Credit Agreements as the “parent entity” thereunder. In addition, New Aptiv is expected to (i) enter into a supplemental indenture to each Indenture pursuant to which New Aptiv will guarantee the Notes and (ii) enter into a guarantee joinder relating to each Credit Agreement pursuant to which New Aptiv will guarantee the obligations under each Credit Agreement. Following the Reorganization, Merger Sub will replace Aptiv PLC as an obligor under the Credit Agreements and the Notes, and New Aptiv will be a guarantor under the Credit Agreements (and will act as the “parent entity” thereunder) and the Indentures. The Reorganization is permitted under the Credit Agreements subject to satisfaction of certain conditions precedent as more particularly set forth therein, which are not expected to materially impact the Reorganization as described herein. Please see “The Reorganization—Treatment of Debt.”

Will the Reorganization affect Aptiv PLC’s ability to access the capital and bank markets in the future?

We do not expect that the Reorganization will have any significant effect on our ability to access the capital or bank markets. We expect to be able to access the capital and bank markets as efficiently and on similar terms as we can today.

What effect would the failure to complete the Reorganization have on Aptiv PLC?

We will incur certain costs whether or not the Reorganization is completed. We will consider all possible alternatives in the event that the Reorganization is not completed. For more information, please see “Risk Factors.”

What are the material tax consequences of the Transaction?

Please read the following questions and answers regarding some of the potential tax consequences of the Transaction. Please refer to “Material Tax Considerations” beginning on page 47 of this Proxy Statement for a description of the material U.S. federal income tax consequences, Jersey tax consequences, Irish tax consequences, and Swiss tax consequences of the Transaction to shareholders of the Company. The actual tax consequences of the Transaction to you may be complex and will depend on your specific situation. You should consult your tax adviser for a full understanding of the tax consequences of the Transaction to you.

Is the Reorganization taxable to me?

For U.S. federal income tax purposes, the Transaction and the Merger are intended to be treated as parts of an integrated series of transactions that will qualify as a “reorganization” for U.S. federal income tax purposes. Assuming the correctness of the foregoing, U.S. Holders (as defined in “Material Tax Considerations—Material U.S. Federal Income Tax Considerations” beginning on page 47 of this Proxy Statement) will not recognize any gain or loss for U.S. federal income tax purposes solely as a result of the Transaction. Please see “Material Tax Considerations—Material U.S. Federal Income Tax Considerations” beginning on page 47 of this Proxy Statement.

Under current Jersey tax legislation, no stamp duty or other transfer tax is chargeable on the transfer of shares in a Jersey company unless such transfer conveys the right to occupy Jersey property. Therefore, no Jersey stamp duty or transfer tax is expected to be payable by Scheme Shareholders (as defined in “Part 3—The Scheme of Arrangement”) on the transfer of their Scheme Shares (as defined in “Part 3—The Scheme of Arrangement”)

10

or on the issue of the New Aptiv Shares. The foregoing is intended as a general guide only to certain Jersey stamp duty and transfer tax considerations applicable to the Scheme and does not constitute tax advice. Specifically, the comments do not address any other Jersey tax considerations that may be relevant for Scheme Shareholders who are residents in Jersey.

Under Swiss tax laws, no tax is generally due for non-Swiss Holders (as defined in “Material Tax Considerations—Material Swiss Tax Considerations”) of Company Shares on the receipt of New Aptiv Shares in the course of the Reorganization. If you are a Swiss Holder and are a beneficial owner of the Company Shares, the Reorganization may result in Swiss tax consequences to you and you are therefore urged to consult with your tax advisor.

The Reorganization is not expected to give rise to any Irish tax for shareholders who are not Irish resident and do not hold their Company Shares in connection with a branch, agency or permanent establishment in Ireland and who are not within the temporary non-Irish residence rules applicable to individuals.

Is the Reorganization a taxable transaction for Aptiv PLC or New Aptiv?

Due to the expected application of certain statutory reliefs or exemptions, the Reorganization is not expected to give rise to Swiss tax for Aptiv PLC or New Aptiv under Swiss tax law. We have obtained tax rulings from competent Swiss tax authorities that the Transaction and the Merger are tax neutral from a Swiss corporate income and capital tax, Swiss withholding tax and Swiss stamp taxes perspective at the level of Aptiv PLC and New Aptiv as well as Aptiv Swiss Holdings, provided certain requirements are met. Due to the expected application of certain statutory reliefs or exemptions, the Reorganization is not expected to give rise to Irish tax for Aptiv PLC or New Aptiv under Irish tax law, and neither Aptiv PLC nor New Aptiv are expected recognize any gain or loss for U.S. federal income tax purposes as a result of the Reorganization.

Will the Transaction affect the Company’s effective tax rate in 2024—or expectations for later years?

We do not anticipate any material changes to our effective tax rate.

What are the most important Swiss corporate tax consequences of tax residence in Switzerland?

Switzerland imposes a corporate income and annual capital tax on holding companies at the federal, cantonal and communal levels. The overall (federal, cantonal, communal) effective corporate income tax rate may vary, but amounts to a maximum of approximately 15 percent in 2024 in Schaffhausen, Switzerland, depending on the amount of taxable net profit and respective cantonal/communal multiplier. However, we may be entitled to a “participation relief” that can effectively eliminate Swiss corporate income taxation on dividend income from qualifying subsidiaries and capital gains on the disposal of qualifying participations in subsidiaries.

New Aptiv will have to withhold a 35% Swiss withholding tax on gross dividend payment amounts and share repurchases, unless such dividend payment or share repurchase is made out of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”). In a tax ruling obtained by New Aptiv, the competent Swiss federal tax authority confirmed that the Transaction will allow for the creation of such qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”). New Aptiv expects to create qualifying capital contribution reserves in an amount equal to approximately $30 billion at the New Aptiv level (which would be subject to formal confirmation by the Swiss federal tax authority after the completion of the Transaction). New Aptiv expects to pay distributions to shareholders out of such reserves, and as a result, any such distributions to shareholders would be exempt from the Swiss withholding tax. However, the amount of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”) may be depleted over time as New Aptiv uses such reserves for distributions to shareholders or share repurchases.

New Aptiv will be subject to a Swiss issuance stamp tax levied at a rate of 1% on the fair value of share issuances and increases of our equity, other than in connection with qualifying restructurings like the

11

Reorganization. In addition, New Aptiv will be subject to some other Swiss indirect taxes (e.g., value added tax (“VAT”) and Swiss securities transfer stamp tax). Please refer to the questions and answers below for Swiss withholding tax implications on future share repurchases and dividend distributions of New Aptiv and to “Material Tax Considerations—Material Swiss Tax Considerations” for a further description of New Aptiv’s corporate income tax treatment.

The above description aims to provide only a very broad overview of some corporate tax aspects in Switzerland and does not purport to be a complete analysis of the tax types and rates that would be relevant for either New Aptiv or its shareholders.

Will there be Swiss withholding tax on future share repurchases, if any, by New Aptiv?

Repurchases of shares for the purposes of capital reduction are treated as a partial liquidation subject to the 35% Swiss withholding tax, regardless of the place of residency of the shareholder. The amount subject to Swiss withholding tax is the difference between the purchase price paid by New Aptiv and the nominal value of such Shares to the extent such amount is not booked against reserves of qualified capital contributions (“Reserven aus Kapitaleinlagen”). In a tax ruling obtained by New Aptiv, the competent Swiss federal tax authority confirmed that the Transaction will allow for the creation of such qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”). New Aptiv expects to create qualifying capital contribution reserves in an amount equal to approximately $30 billion at the New Aptiv level (which would be subject to formal confirmation by the Swiss federal tax authority after the completion of the Transaction). New Aptiv expects to book the difference between the purchase price paid by New Aptiv and the nominal value of repurchased shares against reserves of qualified capital contributions (“Reserven aus Kapitaleinlagen”), and as a result, any such repurchase of shares from shareholders would not be subject to Swiss withholding tax. However, the amount of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”) may be depleted over time as New Aptiv uses such reserves for distributions to shareholders or share repurchases.

The repurchase of shares for purposes other than qualifying capital reduction, such as to retain as treasury shares for use in connection with stock incentive plans, convertible debt or other instruments within certain periods, will generally not be subject to Swiss withholding tax provided the threshold of 10% (or, in certain cases, 20%) of the registered share capital as required by the Swiss Code of Obligation is satisfied and the shares are resold within certain periods prescribed by Swiss law. If New Aptiv purchases its own shares in order to hold them in treasury, it must present the acquired shares on its standalone “statutory” balance sheet as a negative item in its equity. To the extent such negative item is not explicitly allocated to the reserves of capital contributions (“Reserven aus Kapitaleinlagen”) upon acquisition, the Swiss federal withholding tax is due on the difference between the purchase price paid by New Aptiv and the nominal value of such shares to the extent the treasury shares (i) are not within the admissible corporate law thresholds on treasury shares or (ii) the maximum permissible holding period prescribed by Swiss law is exceeded. New Aptiv expects to allocate the negative item against reserves of qualified capital contributions (“Reserven aus Kapitaleinlagen”), and as a result, any such repurchase of shares from shareholders would not be subject to Swiss withholding tax to the extent the treasury shares (i) are not within the admissible corporate law thresholds on treasury shares or (ii) the maximum permissible holding period prescribed by Swiss law is exceeded. However, the amount of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”) may be depleted over time as New Aptiv uses such reserves for distributions to shareholders or share repurchases.

In most instances, Swiss companies listed on the SIX Swiss Exchange (“SIX”) carry out share repurchase programs through a “second trading line” on the SIX. Swiss institutional investors typically purchase shares from shareholders on the open market and then sell the shares on this second trading line back to the company. The Swiss institutional investors are generally able to receive a full refund of the withholding tax. Due to, among other things, the time delay between the sale to the company and the institutional investors’ receipt of the refund, the price companies pay to repurchase their shares has historically been slightly higher than the price of such companies’ shares in ordinary trading on the SIX first trading line.

12

We will not be able to use the SIX second trading line process to repurchase New Aptiv Shares because we do not intend to list New Aptiv Shares on the SIX. We do, however, intend to follow alternative processes to manage Swiss withholding, including the utilization of capital contribution reserves or other established non-SIX secondary line of trading structures, which we expect would enable us to repurchase New Aptiv Shares in a manner that should allow Swiss institutional market participants selling New Aptiv Shares to us to receive a refund of the Swiss withholding tax and, therefore, accomplish the same purpose as share repurchases on the second trading line at substantially the same cost to us and such market participants as share repurchases on a second trading line.

Will there be Swiss withholding tax on future dividends, if any, by New Aptiv?

A Swiss withholding tax of 35% is due on dividends and similar distributions to New Aptiv shareholders from New Aptiv, regardless of the place of residency of the shareholder. New Aptiv will be required to withhold at such rate and remit on a net basis any payments made to a holder of New Aptiv Shares and pay such withheld amounts to the Swiss federal tax administration. The shareholder may be entitled to a full or partial refund of the withholding tax.

However, distributions based upon a capital reduction and distributions paid out from reserves of qualified capital contributions (Reserven aus Kapitaleinlagen) are generally not subject to Swiss federal withholding tax. In a tax ruling obtained by New Aptiv, the competent Swiss federal tax authority confirmed that the Transaction will allow for the creation of such qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”). New Aptiv expects to create qualifying capital contribution reserves in an amount equal to approximately $30 billion at the New Aptiv level (which would be subject to formal confirmation by the Swiss federal tax authority after the completion of the Transaction). New Aptiv expects to pay distributions out of such reserves, and as a result, any such distributions to shareholders will be exempt from the Swiss withholding tax. However, the amount of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”) may be depleted over time as New Aptiv uses such reserves for distributions to shareholders or share repurchases.

Will the Reorganization have any material impact on another company’s ability to acquire Aptiv?

No, the Reorganization should not materially affect the ability of another company to acquire Aptiv. New Aptiv is a Jersey company, and the rights of shareholders of New Aptiv will be substantially identical to the rights of current shareholders of Aptiv PLC. See “Rights of Shareholders and Powers of the Board of Directors.”

When do you expect the Transaction to be completed?

We are working towards completing the Transaction as quickly as possible and, assuming that the required vote of Company shareholders to approve the Scheme Proposal, the Scheme and Articles Amendment Proposal and the Merger Proposal is obtained at the Special Meetings, as well as the necessary regulatory consents and approvals, satisfied or, to the extent applicable, waived (and we do not abandon the Transaction), we expect to do so as soon as practicable following shareholder approval. We currently expect to complete the Transaction in 2024. Please see “Expected Timetable” below for an expected timetable. However, no assurance can be provided as to when or if the transaction will be completed. The Transaction may be abandoned or delayed by our Board at any time prior to the Scheme becoming effective, even though the Scheme may have been approved by our shareholders and sanctioned by the Court and all other conditions to the Transaction may have been satisfied. Please see “The Reorganization—Amendment, Termination or Delay.”

What is the Merger?

Subject to and conditional upon the Scheme becoming effective and on the terms of and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Aptiv PLC, with Aptiv PLC ceasing to exist and Merger Sub continuing as the surviving entity. Merger Sub will be named “Aptiv Swiss Holdings Limited,” will be a private company, and will be a direct, wholly owned subsidiary of New Aptiv.

13

Who is Aptiv Swiss Holdings?

Aptiv Swiss Holdings Limited, which we refer to as Aptiv Swiss Holdings or Merger Sub, is a newly formed Jersey incorporated private limited company and direct, wholly owned subsidiary of New Aptiv. Prior to the Merger, Aptiv Swiss Holdings will have no property, assets, liabilities or operations, other than those incident to its formation. Subject to and conditional upon the Scheme becoming effective, Aptiv Swiss Holdings will merge with and into Aptiv PLC, with Aptiv Swiss Holdings surviving the Merger as a direct, wholly owned subsidiary of New Aptiv and Aptiv PLC ceasing to exist, on the terms of and subject to the conditions set forth in the Merger Agreement.

Are there any conditions to completing the Merger?

Yes. Under the Merger Agreement, the Merger is conditioned upon:

What happens if the Transaction is not completed?

If the Scheme Proposal, the Scheme and Articles Amendment Proposal and the Merger Proposal are not approved by the requisite vote of Company shareholders at the Special Meetings or if the Transaction is not completed for any other reason, Company shareholders will not receive any New Aptiv Shares in exchange for their Company Shares. Instead, Aptiv will remain an independent public company and the Company Shares will continue to be listed and traded on the New York Stock Exchange (“NYSE”).

What will I receive for my Company Shares?

You will receive one ordinary share of New Aptiv for each ordinary share of Aptiv PLC that you held immediately prior to the completion of the Transaction.

14

If the Scheme is approved, do I have to take any action to cancel my Company Shares and receive New Aptiv Shares?

Assuming that the Transaction becomes effective, if you hold your Company Shares in uncertificated book-entry form or through DTC at the time the Transaction is effected (the “Transaction Time”), which we anticipate will be after the close of trading on the NYSE on the day the Scheme becomes effective, and before the opening of trading on the NYSE on the next business day, your Company Shares will be cancelled and New Aptiv Shares will be issued without any action on your part.

If you hold Company Shares directly in certificated form and the Transaction becomes effective, soon after the Transaction Time our Transfer Agent will send you a letter of transmittal, which is to be used to surrender your Aptiv PLC ordinary share certificates and to apply for share certificates evidencing your ownership in New Aptiv. The letter of transmittal will contain instructions explaining the procedure for surrendering Aptiv PLC ordinary share certificates and applying for share certificates evidencing your ownership in New Aptiv. You should not return share certificates with the enclosed proxy cards.

Can I trade Company Shares between the date of this Proxy Statement and the effective time of the Transaction?

Yes. The Company Shares will continue to trade during this period.

What if I sell my Company Shares after the Beneficial Holder Record Time or the Voting Record Time (as applicable)?

If you transfer your shares after the Beneficial Holder Record Time or the Voting Record Time (whichever is applicable to you) but before either Special Meeting, you will retain your right to vote at both Special Meetings but will have transferred the right to receive the Scheme consideration of New Aptiv Shares. In order to receive the Scheme consideration you must hold your shares through the completion of the Transaction.

What if I buy Company Shares after the Beneficial Holder Record Time or the Voting Record Time (as applicable)?

If you acquire additional Company Shares from a beneficial holder after the Beneficial Holder Record Time or a shareholder of record after the Voting Record Time, you will not have the right to vote in respect of those additional Company Shares at either Special Meeting. You will have the right to receive the Scheme consideration of New Aptiv Shares in respect of those additional Company Shares if you hold such shares through the completion of the Transaction.

How will the Transaction affect the stock exchange listing of the Company Shares?

We expect that, immediately following the Transaction Time, the New Aptiv Shares will be listed on the NYSE under the symbol “APTV,” the same symbol under which your Company Shares are currently listed.

15

EXPECTED TIMETABLE

All times shown are New York times unless otherwise stated. All dates and times are based on current expectations of Aptiv and are subject to change. If any of these dates and / or times changes, Aptiv will be publicly announce such changes.

16

17

18

19

20

21

22

23

24

25

26

RISK FACTORS

Before you decide how to vote on the matters described in this Proxy Statement, you should consider carefully the following risk factors, in addition to the other information contained in this Proxy Statement and the documents incorporated by reference, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent filings with the SEC.

The market for the New Aptiv Shares may differ from the market for the Company Shares.

We intend to list the New Aptiv Shares on the NYSE under the symbol “APTV,” the same trading symbol under which Company Shares trade. The market price, trading volume or volatility of the New Aptiv Shares could be different from those of the Company Shares.

The Reorganization may not allow us to maintain a competitive worldwide effective corporate tax rate.

We cannot give any assurance as to what our effective tax rate will be after the Reorganization because of, among other things, uncertainty regarding the application of the tax laws and policies of the jurisdictions where we operate. Our actual effective tax rate may vary from this expectation, and that variance may be material. Additionally, the tax laws of Switzerland and other jurisdictions could change in the future, and such changes could cause a material change in our effective tax rate.

Legislative and regulatory action could materially and adversely affect us.

Our tax position could be adversely impacted by changes in the tax laws, tax treaties or tax regulations or the interpretation or enforcement thereof by any tax authority. For example, legislative action may be taken by the U.S. Congress which, if ultimately enacted, could override tax treaties upon which we rely or could broaden the circumstances under which we would be considered a U.S. resident, which could materially and adversely affect our effective tax rate and cash tax position. We cannot predict the outcome of any specific legislative proposals. If proposals were enacted that had the effect of limiting our ability to take advantage of the tax treaties between Switzerland and other jurisdictions (including the U.S.), we could be subjected to increased taxation. In addition, any future amendments to the current income tax treaties between Switzerland and the other jurisdictions (including the U.S.) could subject us to increased taxation.

We will be subject to various Swiss taxes as a result of the Reorganization.

We will be subject to additional corporate income and annual capital taxes in Switzerland as a result of the Reorganization. Switzerland imposes a corporate income tax on holding companies at the federal, cantonal and communal levels. The overall (federal, cantonal, communal) effective corporate income tax rate may vary, but amounts to a maximum of approximately 15 percent in 2024 in Schaffhausen, Switzerland, depending on the amount of taxable net profit and respective cantonal/communal multiplier. However, we will be entitled to a “participation relief” that can effectively eliminate Swiss corporate income taxation on qualifying dividend income from subsidiaries and capital gains on the disposal of qualifying participations in subsidiaries.

New Aptiv will have to withhold a 35% Swiss withholding tax on gross dividend payment amounts and share repurchases, unless such dividend payment or share repurchase is made out of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”). In a tax ruling obtained by New Aptiv, the competent Swiss federal tax authority confirmed that the Transaction will allow for the creation of such qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”). New Aptiv expects to create qualifying capital contribution reserves in an amount equal to approximately $30 billion at the New Aptiv level (which would be subject to formal confirmation by the Swiss federal tax authority after the completion of the Transaction). New Aptiv expects to pay distributions to shareholders out of such reserves, and as a result, any such distributions to shareholders would be exempt from the Swiss withholding tax. However, there can be no assurance that the

27

Swiss withholding rules will not be changed in the future. Further, the amount of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”) may be depleted over time as New Aptiv uses such reserves for distributions to shareholders or share repurchases. If New Aptiv is unable to make a distribution out of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”), then any dividends paid by New Aptiv and share repurchases will generally be subject to a Swiss withholding tax at a rate of 35%.

We will also be subject to a Swiss issuance stamp tax levied at a rate of 1 percent on the fair value of share issuances and increases of our equity, other than in connection with qualifying restructurings like the Reorganization. In addition, New Aptiv will be subject to some other Swiss indirect taxes (e.g., VAT and Swiss securities transfer stamp tax).

If the Court does not sanction the Scheme, Aptiv PLC will not have the ability to effect the Reorganization.

We cannot proceed with the Reorganization unless the Court sanctions the Scheme after conducting the Court Hearing. Assuming that the Court Meeting is conducted in accordance with the order of the Court and that the requisite majority of shareholders approve the Scheme Proposal, we are not aware of any reason why the Court would not sanction the Scheme. Nevertheless, the sanction of the Court to the Scheme is a matter for its discretion and there can be no assurance if or when such sanction will be obtained.

If the Court does not sanction the Scheme, Aptiv PLC will be unable to effect the Reorganization as contemplated under the Scheme (even if the requisite shareholders have approved the Scheme). In addition, the Court may impose such conditions, modifications or amendments as it deems appropriate in relation to the Scheme, but may not impose any material changes without the joint consent of Aptiv PLC and New Aptiv. If such conditions, modifications or amendments are imposed, Aptiv PLC will be unable to effect the Reorganization without amending the Scheme, which, depending on the nature of such conditions, modifications or amendments, might require new shareholder approvals.

Following the completion of the Reorganization, it is possible that we will be removed from the S&P 500 stock index and other indices, which could have an adverse impact on our share price.

Company Shares are currently a component of the S&P 500 stock index and other indices. Based on current S&P guidelines, we believe that New Aptiv Shares will continue to meet S&P criteria for inclusion in the S&P 500 stock index upon completion of the Reorganization. Nonetheless, S&P retains discretion to determine whether the New Aptiv Shares should continue as a component of the S&P 500 stock index upon the completion of the Reorganization.

We expect that S&P will determine whether the New Aptiv Shares qualify for inclusion in the S&P 500 stock index shortly following the Reorganization. If the New Aptiv Shares were not included as a component of the S&P 500 stock index or other indices or if we no longer meet the qualifications of such indices, institutional investors that are required to track the performance of the S&P 500 stock index or such other indices or the funds that impose those qualifications would potentially be required to sell their New Aptiv Shares, which could adversely affect the price thereof.

The Reorganization will result in additional direct and indirect costs, even if the Reorganization is not completed.

Although we do not expect these costs to be material, we will incur additional direct costs as a result of the Reorganization. We have incurred attorneys’ fees and accountants’ fees in connection with a reorganization of the Company’s subsidiaries in preparation for the Reorganization. In addition, we expect to incur attorneys’ fees, accountants’ fees, filing fees, mailing expenses and financial printing expenses in connection with the Reorganization, even if the Scheme is not approved or completed. The Reorganization also may negatively affect us by diverting attention of our management and employees from our operating business during the period of implementation and by increasing other administrative costs and expenses.

28

We may choose to abandon or delay the Transaction.

We may abandon or delay the Transaction at any time prior to the Scheme becoming effective by action of our Board, even after the Special Meetings and the sanction of the Court. While we currently expect the Transaction to take place as soon as practicable after obtaining shareholder approval of the Scheme at the Court Meeting, our Board may delay the Transaction for a significant time or may abandon the Transaction after the Special Meetings because, among other reasons, of an increase in our estimated cost of the Transaction or a determination by the Board that the Transaction is no longer in the best interests of the Aptiv shareholders or may not result in the benefits we expect. Please see “The Reorganization—Amendment, Termination or Delay.”

29

FORWARD-LOOKING STATEMENTS

We have made forward-looking statements in this Proxy Statement and the documents incorporated by reference in this Proxy Statement that are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, financing plans, competitive position, potential growth opportunities, potential operating performance improvements, the effects of competition and the effects of future legislation or regulations. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words “believe,” “expect,” “plan,” “intend,” “anticipate,” “estimate,” “predict,” “potential,” “continue,” “may,” “should” or the negative of these terms or similar expressions.

Forward-looking statements involve risks, uncertainties and assumptions. Actual results may differ materially from those expressed in these forward-looking statements. You should not put undue reliance on any forward-looking statements.

The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, our ability to obtain approval of the Company’s shareholders and the Court for, and to satisfy the other conditions to, the Reorganization on the expected time frame or at all; our ability to realize the expected benefits from the Reorganization; the occurrence of difficulties in connection with the Reorganization; any unanticipated costs in connection with the Reorganization; global and regional economic conditions, including conditions affecting the credit market; global inflationary pressures; uncertainties created by the conflict between Ukraine and Russia, and its impacts to the European and global economies and our operations in each country; uncertainties created by the conflicts in the Middle East and their impacts on global economies; fluctuations in interest rates and foreign currency exchange rates; the cyclical nature of global automotive sales and production; the potential disruptions in the supply of and changes in the competitive environment for raw material and other components integral to the Company’s products, including the ongoing semiconductor supply shortage; the Company’s ability to maintain contracts that are critical to its operations; potential changes to beneficial free trade laws and regulations, such as the United States-Mexico-Canada Agreement; changes to tax laws; future significant public health crises; the ability of the Company to integrate and realize the expected benefits of recent transactions; the ability of the Company to attract, motivate and/or retain key executives; the ability of the Company to avoid or continue to operate during a strike, or partial work stoppage or slow down by any of its unionized employees or those of its principal customers; and the ability of the Company to attract and retain customers.

The above factors are in addition to those factors discussed under “Risk Factors” and “The Reorganization—Background and Reasons for the Reorganization” and elsewhere in this Proxy Statement, as well as those in the documents that we incorporate by reference into this Proxy Statement (including, without limitation, the “Risk Factors” section of our Annual Report and subsequent SEC filings). There may be other risks and uncertainties that we are unable to predict at this time or that we currently do not expect to have a material adverse effect on our business. We expressly disclaim any obligation to update these forward-looking statements other than as required by law.

30

PART 1—THE TRANSACTION AND THE SPECIAL MEETINGS

THE SPECIAL MEETINGS OF COMPANY SHAREHOLDERS

Overview

This Proxy Statement is being provided to Company shareholders as part of a solicitation of proxies by the Board for use at the Special Meetings of Company shareholders referred to below and at any adjournment or postponement of such meetings. This Proxy Statement is being furnished to Company shareholders on or about November 6, 2024. This Proxy Statement provides Company shareholders with information they need to be able to vote or instruct their vote to be cast at the Special Meetings.

Time, Place, Date and Purpose of the Special Meetings

Court Meeting

The Court Meeting, which will be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210, has been convened for December 2, 2024 at 1:00 p.m. (Eastern time). At the Court Meeting, the Company shareholders will be asked to vote to approve the Scheme Proposal.

Extraordinary General Meeting

Aptiv has also convened an Extraordinary General Meeting of shareholders to be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210 on December 2, 2024 at 1:15 p.m. (Eastern time), or, if the Court Meeting has not concluded by 1:15 p.m. (Eastern time), as soon as possible after the conclusion of the Court Meeting. At the Extraordinary General Meeting, the Company shareholders will be asked to vote to approve the Scheme and Articles Amendment Proposal and the Merger Proposal.

Attendance

Attendance at the Court Meeting and the Extraordinary General Meeting is limited to Company shareholders of record as of the Voting Record Time. Shareholders of record are entitled to vote at the Court Meeting and the Extraordinary General Meeting or they may appoint another person or persons, whether a shareholder of Aptiv or not, as their proxy or proxies, to exercise all or any of their rights to attend, speak and vote at the Court Meeting and the Extraordinary General Meeting.

Company shareholders who beneficially own Company Shares for which Cede & Co. is the registered holder (as nominee for The Depository Trust Company) and whose interests in Company Shares are held in “street name” by a broker, bank, trust or other nominee as of the Beneficial Holder Record Time (the close of business (Eastern time) on October 31, 2024) will be entitled to direct his, her or its broker, bank, trust or other nominee how to vote such beneficially held shares at the Court Meeting and the Extraordinary General Meeting. Only a broker, bank, trust or other nominee of a beneficial holder can vote such beneficially held shares and the vote cannot be cast unless such beneficial holder provides instructions to such broker, bank, trust or other nominee, or obtains a legal proxy from such broker, bank, trust or other nominee, which entitles such beneficial holder to vote such shares as a proxy for the shareholder of record. To register to attend the Special Meetings and vote during the meeting, beneficial holders must request a legal proxy from their broker, bank, trust or other nominee. Requests for registration must be received no later than 5:00 p.m. (Eastern time) on November 22, 2024 in order to ensure timely registration.

Proposals

Court Meeting: Company shareholders entitled to vote at the Court Meeting are being asked to consider the following proposal to approve the Scheme:

31

Extraordinary General Meeting: Company shareholders entitled to vote at the Extraordinary General Meeting are also being asked to consider and authorize and approve, as applicable, the following related proposal to effect the Scheme:

Record Time; Outstanding Company Shares; Company Shares Entitled to Vote

Only beneficial holders of Company Shares as of the Beneficial Holder Record Time will be entitled to receive notice of and to direct their brokers, banks, trusts or other nominees how to vote such beneficially held shares at the Special Meetings, or any adjournment or postponement thereof. Only shareholders of record as of the Voting Record Time will be entitled to vote at the Special Meetings or any adjournment or postponement thereof (in person or by proxy). As of October 31, 2024, there were 235,035,739 Company Shares outstanding. Each outstanding Company share is entitled to one vote on each proposal and any other matter properly coming before the Special Meetings.

Quorum

Two or more Scheme Shareholders that are present (in person or by proxy) will constitute a quorum for the Court Meeting. One or more Company shareholders that are present (in person or by proxy) representing a majority of the voting power of Aptiv will constitute a quorum for the Extraordinary General Meeting. Aptiv does not currently hold any Company Shares in treasury (although any such shares would not be included in the calculation of the number of Company Shares present at the Special Meetings for purposes of determining a quorum in any event). The Company’s inspector of election intends to treat as “present” for these purposes shareholders who have submitted, properly executed or if applicable, transmitted proxies with respect to the Extraordinary General Meeting that are marked “abstain.” The Company’s inspector of election will also treat as “present” shares held in “street name” by brokers that are voted by such brokers that have not been directed by the beneficial owners to vote on any resolution in any particular manner.

Company Share Ownership and Voting by Aptiv Directors and Officers

As of October 28, 2024, the full Board and named executive officers had the right to vote, in the aggregate, 908,597 of the then-outstanding Company Shares at the Special Meetings representing less than one percent of the Company Shares then outstanding and entitled to vote at the Court Meeting and less than one percent of the Company Shares then outstanding and entitled to vote at the Extraordinary General Meeting. Board members and named executive officers who are shareholders of Aptiv intend to vote “FOR” the Scheme at the Court Meeting, and “FOR” the Scheme and Articles Amendment Proposal and the Merger Proposal at the Extraordinary General Meeting.

32

Vote Required; Recommendation of the Board

Court Meeting

Proposal to approve the Scheme: Company shareholders are being asked to vote on a proposal to approve the Scheme at the Court Meeting. As set out in full under the section entitled “Part 2—Explanatory Statement—4. Court Meeting and Extraordinary General Meeting” beginning on page 69, the Scheme Proposal requires the approval by (a) a majority in number of the Company shareholders of record as of the Voting Record Time that are present and voting (in person or by proxy) at the Court Meeting (or at any adjournment or postponement of such meeting) and (b) at least 75% of the votes cast by the Company shareholders present and voting (in person or by proxy).

The vote required to approve the Scheme Proposal at the Court Meeting is based on votes properly cast at the meeting. In accordance with Jersey law, Company shareholders will not be permitted to abstain with respect to the Scheme Proposal. Broker non-votes are not considered votes properly cast and will have no effect on such proposal.

The Transaction is conditioned on approval of the Scheme at the Court Meeting.

The Board recommends that Company shareholders vote “FOR” the proposal to approve the Scheme at the Court Meeting.

Extraordinary General Meeting

The following resolutions are proposed to be voted on at the Extraordinary General Meeting:

Special Resolutions:

At the Extraordinary General Meeting, the requisite approval of each of the resolutions depends on whether it is an “ordinary resolution”, which requires the approval of at least a majority of the votes cast by the holders of Company Shares present and voting (in person or by proxy), or a “special resolution”, which requires the approval of at least two-thirds (2/3) of the votes cast by the holders of Company Shares present and voting (in person or by proxy), in each case, entitled to vote on the subject matter (provided a quorum is present). The Company Shareholder Proposals are “special resolutions” requiring approval of at least two-thirds (2/3) of the votes cast by Company shareholders present and voting (in person or by proxy) at the Extraordinary General Meeting.

The votes required to approve the Company Shareholder Proposals are based on votes properly cast at the Extraordinary General Meeting. Because abstentions and broker non-votes are not considered votes properly cast, abstentions and broker non-votes, will have no effect on the Company Shareholder Proposals.

33

A broker non-vote generally occurs when a broker, bank, trust or other nominee holding shares on your behalf does not vote on a proposal because the broker, bank, trust or other nominee has not received your voting instructions and lacks discretionary power to vote the shares. Broker non-votes, if any, will be counted for the purpose of determining whether a quorum is present at the Special Meetings.

After careful consideration, the Board has (i) approved and declared advisable the Scheme and the Merger, and (ii) declared that it is in the best interests of Company shareholders that Aptiv consummate the Scheme and the Merger.

The Board recommends that Company shareholders vote “FOR” the proposals to approve each of the resolutions.

Voting Your Company Shares

Company shareholders whose names appear in the register of shareholders of Aptiv are considered shareholders of record and are entitled to attend and vote at the Special Meetings or they may appoint another person or persons, whether a shareholder of Aptiv or not, as their proxy or proxies, to exercise all or any of their rights to attend and vote at the Special Meetings. Aptiv recommends that you submit your proxy even if you plan to attend either or both Special Meetings. If you vote by proxy, you may change your vote, among other ways, if you attend and vote at either or both Special Meetings. Only shareholders of record as of the Voting Record Time will have the right to attend and vote at the Special Meetings.

If you are a shareholder of record, you may use the forms of proxy that you receive to tell the persons named as proxies how to vote your Company Shares.

If you properly complete, sign and date your form of proxy, your Company shares will be voted in accordance with your instructions. The named proxies will vote all Company shares at the Special Meeting for which proxies have been properly submitted and not revoked. If you sign and return your forms of proxy appointing the individuals referred to on the forms of proxy as your proxy but do not mark your forms to tell the proxy how to vote on a proposal, your shares will be voted in respect of such proposal at the discretion of the named proxies.

Company shareholders of record may also vote by telephone at 1-800-690-6903 or over the internet at www.proxyvote.com. Voting instructions can be found on the forms of proxy you received for the Special Meetings. Either method of submitting a proxy will enable your Company Shares to be represented and voted at the applicable Special Meeting.

Voting Company Shares Held in Street Name

Company shareholders who beneficially own Company Shares for which Cede & Co. is the registered holder (as nominee for The Depository Trust Company) and whose interests in Company Shares are held in “street name” by a broker, bank, trust or other nominee as of the Beneficial Holder Record Time, will be entitled to direct his, her or its broker, bank, trust or other nominee how to vote such beneficially held shares at the Special Meetings following the instructions that the broker, bank, trust or other nominee provides you along with this Proxy Statement. To register to attend the Special Meetings and vote during the meeting, beneficial holders must request a legal proxy from their broker, bank, trust or other nominee. Requests for registration must be received no later than 5:00 p.m. (Eastern time) on November 22, 2024 in order to ensure timely registration.

Your broker, bank, trust or other nominee may have an earlier deadline by which you must provide instructions to it as to how to vote your shares, so you should read carefully the materials provided to you by your broker, bank, trust or other nominee. Only beneficial owners of Company Shares as of the Beneficial Holder Record Time will have the right to direct their broker, bank, trust or other nominee how to vote such Company Shares.

34

If you do not provide a signed voting instruction form to your broker, bank, trust or other nominee, your Company Shares will not be voted on any proposal on which the broker, bank, trust or other nominee does not have discretionary authority to vote. This is referred to in this Proxy Statement and in general as a broker non-vote. In these cases, the broker, bank, trust or other nominee will not be able to vote your shares on those matters for which specific authorization is required. Brokers do not have discretionary authority to vote on any of the proposals at either Special Meeting.

Accordingly, if you fail to provide a signed voting instruction form to your broker, bank, trust or other nominee, your shares held through such broker, bank, trust or other nominee will not be voted at either Special Meeting.

YOUR VOTE IS VERY IMPORTANT. SHAREHOLDERS OF RECORD ARE RECEIVING A SINGLE MAILING THAT INCLUDES FORMS OF PROXIES WITH INSTRUCTIONS FOR VOTING AT EACH OF THE COURT MEETING AND THE EXTRAORDINARY GENERAL MEETING. YOU ARE ENCOURAGED TO SUBMIT A FORM OF PROXY (OR VOTE BY TELEPHONE OR OVER THE INTERNET FOLLOWING THE INSTRUCTIONS PROVIDED IN THE FORM OF PROXY) FOR EACH OF THE COURT MEETING AND THE EXTRAORDINARY GENERAL MEETING AS SOON AS POSSIBLE. BENEFICIAL HOLDERS WILL RECEIVE VOTING INSTRUCTIONS APPLICABLE TO EACH SPECIAL MEETING FROM THEIR BROKER, BANK, TRUST OR OTHER NOMINEE. BENEFICIAL HOLDERS SHOULD FOLLOW THE DIRECTIONS PROVIDED BY THEIR BROKER, BANK, TRUST OR OTHER NOMINEE REGARDING HOW TO INSTRUCT SUCH BROKER, BANK, TRUST OR NOMINEE TO VOTE THEIR BENEFICIALLY HELD SHARES.

Revoking Your Proxy

If you are a shareholder of record, you may revoke your proxy before it is voted at the Court Meeting or before your proxy is voted at the Extraordinary General Meeting by:

If you are a beneficial holder with shares held in “street name” by a broker, bank, trust or other nominee, you should follow the instructions of your broker, bank, trust or other nominee regarding the revocation of proxies.

35

THE REORGANIZATION

The Transaction will result in the establishment of New Aptiv, as our new publicly listed parent Company, which will be tax resident in Switzerland.

As explained in more detail below, the Scheme on which we are asking you to vote will effect the Transaction, which is part of a broader Reorganization.

The Transaction involves several steps, part of which is being implemented by means of a Court-sanctioned Scheme between Aptiv and the Scheme Shareholders under Part 18A of the Companies Law. Implementation of the Scheme requires approval of the Scheme by the Scheme Shareholders at the Court Meeting and the passing of the proposed resolutions at the Extraordinary General Meeting being held in connection with the Scheme. The Scheme also requires the sanction of the Court. The Scheme is set out in full in Part 3 of this Proxy Statement titled “The Scheme of Arrangement”.

The purpose of the Scheme is to provide for New Aptiv to acquire the entire issued and to be issued ordinary share capital of Aptiv. This is to be achieved by New Aptiv acquiring the Scheme Shares held by the Scheme Shareholders as of the Scheme Record Time, in consideration for which New Aptiv will issue, one ordinary share of $0.01 each (“New Aptiv Share”) to the Scheme Shareholders in exchange for each Scheme Share transferred.

The Scheme requires, among other things, an application by Aptiv to the Court to sanction the Scheme. A scheme of arrangement is a statutory procedure under the Companies Law, pursuant to which the Court may approve an arrangement between Aptiv and its shareholders. In the Scheme, Aptiv will make an initial application to the Court to convene the Court Meeting at which (a) a majority in number of the Company shareholders of record as of the Voting Record Time that are present and voting (in person or by proxy) at the Court Meeting and (b) at least 75% of the votes cast by the Company shareholders present and voting (in person or by proxy) must approve the Scheme by which they will transfer their Company Shares in exchange for New Aptiv Shares. If the Company shareholders so agree by approving the Scheme, subject to the satisfaction or waiver of the conditions set forth in the Scheme, Aptiv will return to the Court to request the Court to sanction the Scheme. Shareholders are entitled to attend to support or oppose the sanction of the Scheme by the Court as described elsewhere in this Proxy Statement. Upon the Scheme becoming effective in accordance with its terms and the Companies Law, it will bind Aptiv and its shareholders.

The Scheme and the Transaction are subject to a number of conditions which are summarized in the section captioned “—Conditions to Consummation of the Transaction.”

Assuming we receive the necessary approvals from the shareholders at the Court Meeting, the Court sanctions the Scheme and the conditions to consummation of the Transaction are satisfied (and we do not abandon the Transaction), we will file the Court Order with the Registrar of Companies in Jersey, at which time the Scheme will be effective. Various steps of the Transaction will occur effectively simultaneously at the Transaction Time, which we anticipate will be after the close of trading on the NYSE on the day the Scheme becomes effective, and before the opening of trading on the NYSE on the next business day.

At the Transaction Time, the following steps will occur effectively simultaneously:

36

As a result of the Transaction, the holders of Company Shares will become ordinary shareholders of New Aptiv and Aptiv PLC will become a wholly owned subsidiary of New Aptiv. After the Transaction, New Aptiv will be renamed “Aptiv PLC.”

In connection with consummation of the Transaction:

We refer to the foregoing transactions, together with the steps of the Transaction, as the Reorganization.

As of October 31, 2024, there were 235,035,739 Company Shares outstanding. In addition, as of October 31, 2024, there were 32,777,116 Company Shares reserved for issuance pursuant to outstanding equity awards and Aptiv PLC’s Long-Term Incentive Plan.

After the Transaction, you will continue to own an interest in a parent company that will continue to conduct the same business operations as conducted by Aptiv PLC before the Transaction. The number of shares you will own in New Aptiv will be the same as the number of shares you owned in Aptiv PLC immediately prior to the Transaction, and your relative economic interest in Aptiv will remain unchanged.

Upon completion of the Reorganization, we will remain subject to SEC reporting requirements, the mandates of the Sarbanes-Oxley Act and the applicable corporate governance rules of the NYSE, and we will continue to report our consolidated financial results in U.S. dollars and in accordance with U.S. GAAP.

Background and Reasons for the Reorganization

Our board of directors has determined that it is in the best interests of Aptiv and its shareholders to establish New Aptiv as our new publicly listed parent company, which will be resident for tax purposes in Switzerland and that doing so would result in substantial benefits, including the following:

37

We believe that our publicly listed parent company should remain organized in Jersey given the flexible nature of Jersey corporate law. We believe that it is in the best interests of Aptiv and its shareholders to establish a new parent company, New Aptiv, rather than to undertake another form of transaction.

We cannot assure you that the anticipated benefits of the Reorganization will be realized. In addition to the potential benefits described above, the Reorganization will expose you and us to some risks. These risks include the following: the market for the New Aptiv Shares may differ from the market for Company Shares; the Reorganization may not allow us to maintain a competitive worldwide effective corporate tax rate; legislative and regulatory action could materially and adversely affect us; we will be subject to various Swiss taxes as a result of the Reorganization; if the Court does not approve the Scheme, Aptiv PLC will not have the ability to effect the Reorganization; following the completion of the Reorganization, it is possible that we will be removed from the S&P 500 stock index and other indices, which could have an adverse impact on our share price; the Reorganization will result in additional direct and indirect costs, even if the Reorganization is not completed; and we may choose to abandon or delay the Transaction. Please see the discussion under “Risk Factors.” Our Board has considered both the potential advantages of the Reorganization and these risks and has unanimously approved the Scheme and recommended that the shareholders vote for the Scheme.

Amendment, Termination or Delay

Subject to U.S. securities law constraints, the Scheme may be amended, modified or supplemented at any time before or after its approval by the shareholders of Aptiv PLC at the Court Meeting. However, after adoption, no amendment, modification or supplement may be made or effected that legally requires further approval by Aptiv PLC shareholders without obtaining that approval.

At the Court Hearing, the Court may impose such conditions as it deems appropriate in relation to the Scheme but may not impose any material changes without the joint consent of Aptiv PLC and New Aptiv. Aptiv PLC may, subject to U.S. securities law constraints, consent to any modification of the Scheme on behalf of the shareholders which the Court may think fit to approve or impose.

The Board of Aptiv PLC may terminate the Scheme and abandon the Transaction, or delay the Transaction, at any time prior to the effectiveness of the Scheme without obtaining the approval of Aptiv PLC shareholders, even though the Scheme may have been approved by our shareholders and sanctioned by the Court and all other conditions to the Transaction may have been satisfied.

Unless the Scheme has become effective on or before June 30, 2025 or such later date, if any, as Aptiv PLC may agree and the Court may allow, the Scheme will lapse by its terms and not come into effect.

Conditions to Consummation of the Transaction

The Transaction will not be completed unless, among other things, the following conditions are satisfied or, if allowed by law, waived:

38

Court Sanction of the Scheme

Pursuant to Article 125 of the Companies Law, the Scheme must be sanctioned by the Court.

The Transaction is being implemented by way of Scheme, which requires, among other things, an application by Aptiv to the Court to sanction the Scheme. A scheme of arrangement is a statutory procedure under the Companies Law, pursuant to which the Court may approve an arrangement between Aptiv and its shareholders. In the Scheme, Aptiv will make an initial application to the Court to convene the Court Meeting at which (a) a majority in number of the Company shareholders of record as of the Voting Record Time that are present and voting (in person or by proxy) at the Court Meeting and (b) at least 75% of the votes cast by the Company shareholders present and voting (in person or by proxy) must approve the Scheme by which they will transfer their Company Shares in exchange for New Aptiv Shares.

Prior to the mailing of this Proxy Statement, Aptiv obtained directions from the Court providing for the convening of the Court Meeting and other procedural matters regarding the meeting. A copy of the Court’s directions is attached as Annex B to this Proxy Statement.

If the Company shareholders so agree by approving the Scheme, subject to the satisfaction or waiver of the conditions set forth in the Scheme, Aptiv will return to the Court to request the Court to sanction the Scheme. Shareholders are entitled to attend to support or oppose the sanction of the Scheme by the Court as described elsewhere in this Proxy Statement.

The Scheme is set out in full in “Part 3—The Scheme of Arrangement” of this Proxy Statement. At the Court Meeting, Aptiv ordinary shareholders will be asked to approve the Scheme. If the shareholders approve the Scheme, then Aptiv intends to apply for sanction of the Scheme at the Court Hearing. We encourage you to read the Scheme in its entirety for a complete description of its terms and conditions.

At the Court Hearing, the Court may impose such conditions as it deems appropriate in relation to the Scheme but may not impose any material changes without the joint consent of Aptiv and New Aptiv. Aptiv may, subject to U.S. securities law constraints, consent to any modification of the Scheme on behalf of the shareholders which the Court may think fit to approve or impose. In determining whether to exercise its discretion and sanction the Scheme, the Court will determine, among other things, whether the Scheme is fair to Aptiv’s ordinary shareholders. We expect the Court Hearing to be held on December 13, 2024 10:00 a.m. (Jersey time) at the Court.

Upon the Scheme becoming effective in accordance with its terms and the Companies Law, it will bind Aptiv and its shareholders.

If you are an ordinary shareholder who wishes to appear in person or by counsel at the Court Hearing and present evidence or arguments in support of or opposition to the Scheme, you may do so. In addition, the Court

39

has wide discretion to hear from interested parties. Aptiv PLC will not object to the participation in the Court Hearing by any shareholder who holds shares through a broker. In accordance with its terms, the Scheme will become effective as soon as a copy of the Court Order of sanctioning the Scheme has been delivered to the Registrar of Companies in Jersey as required by the Companies Law. Please see “—Conditions to Consummation of the Transaction” for more information on the conditions to the Transaction.

Once the Scheme is effective, the Court will have exclusive jurisdiction to hear and determine any suit, action or proceeding and to settle any dispute which arises out of or is connected with the terms of the Scheme or its implementation or out of any action taken or omitted to be taken under the Scheme or in connection with the administration of the Scheme. A shareholder who wishes to enforce any rights under the Scheme after such time must notify Aptiv in writing of its intention at least five business days prior to commencing a new proceeding. After the date on which the Scheme becomes effective (the “Effective Date”), no shareholder may commence a proceeding against New Aptiv or Aptiv in respect of or arising from the Scheme except to enforce its rights under the Scheme where a party has failed to perform its obligations under the Scheme.

When under any provision of the Scheme a matter is to be determined by Aptiv, then Aptiv will have discretion to interpret those matters under the Scheme in a manner that it considers fair and reasonable, and its decisions will be binding on all concerned.

The Merger

If the Merger Proposal is approved by the shareholders of Aptiv, subject to and conditional upon the Scheme becoming effective, on the terms of and subject to the conditions set forth in the Merger Agreement, Merger Sub will be merged with and into Aptiv PLC, with Aptiv PLC ceasing to exist and Aptiv Swiss Holdings continuing as the surviving entity. Merger Sub will be named “Aptiv Swiss Holdings Limited,” will be a private company, and will be a direct, wholly owned subsidiary of New Aptiv. As a result of the Merger, the separate existence of Aptiv PLC will cease on the date which the last entry on the register of companies in Jersey is made under Article 127FM of the Companies Law in relation to the Merger, and all property, rights, privileges, powers and franchises of Aptiv PLC will vest in Merger Sub on completion of the Merger, and all debts, liabilities and duties of Aptiv PLC will become the debts, liabilities and duties of Merger Sub on completion of the Merger. It is currently expected that the Merger will complete shortly after the Effective Date.

The Merger Agreement

Conditions to the Merger

Under the Merger Agreement, the Merger is conditioned upon:

40

Representations and Warranties

The Merger Agreement contains certain representations and warranties relating to organization and good standing, due authorization and enforceability of the Merger Agreement, in each case, on the part of Aptiv PLC, New Aptiv and Aptiv Swiss Holdings.

Governing Law

The Merger Agreement will be governed by and construed in accordance with the laws of Jersey.

Creditor Notice

In accordance with Article 127FC of the Companies Law, the Company will send, at the same time as this proxy statement, written notice to each of its creditors who, after its directors have made reasonable enquiries, is known to the directors to have a claim against the Company exceeding £5,000.

Regulatory Matters

Other than the delivery to the registrar of companies in Jersey of all documents required in accordance with Article 127FJ of the Companies Law for the purposes of effecting the Merger, we are not aware of any governmental approvals or actions that are required to complete the Merger other than compliance with various portions of Jersey corporate law.

Dissenters’ Rights

Pursuant to Article 127FB of the Companies Law, following the approval by shareholders of Aptiv of the Merger, you have the right to apply to the Royal Court on the grounds that the Merger would unfairly prejudice your interests.

An application to the Royal Court objecting to the Merger may not be made: (i) more than 21 days after the Merger has been approved by the shareholders of Aptiv; or (ii) if you voted in favor of the Merger. The Companies Law does not preclude a member who fails to vote on the Merger from making such an application. In view of this, dissenters and abstainers may bring such an application to court.

On an application to the Royal Court in objection of the Merger, the Royal Court may, if satisfied that such application is well-founded, make an order as it thinks fit for giving relief in respect of the matters companied of. Such order will typically be tailored to the relief sought by the applicant but may include a restraint on the Merger, impose conditions on the Merger or provide for the purchase of the shares of the applicant Aptiv shareholder by other members of Aptiv or Aptiv itself.

41

Accompanying Documents

In accordance with Article 127F of the Companies Law, this Proxy Statement is accompanied by the following attached hereto as Annex C:

Material Interests under Article 127F(2)(a)(v) of the Companies Law

Aptiv PLC

The directors of Aptiv PLC and their share ownership are listed under “Security Ownership of Management and Directors.”

Following the consummation of the Transaction and immediately prior to the Merger, New Aptiv will be the sole shareholder of Aptiv PLC.

Aptiv Swiss Holdings

Two current Aptiv employees, who also serve as directors of various Aptiv subsidiaries, are directors of Aptiv Swiss Holdings.

New Aptiv is, and immediately prior to the Merger will be, the sole shareholder of Aptiv Swiss Holdings.

Federal Securities Law Consequences; Resale Restrictions

The issuance of New Aptiv Shares to Aptiv PLC’s shareholders in connection with the Transaction will not be registered under the Securities Act. Section 3(a)(10) of the Securities Act exempts securities issued in exchange for one or more outstanding securities from the general requirement of registration where the terms and conditions of the issuance and exchange of such securities have been approved by any court of competent jurisdiction, after a hearing upon the fairness of the terms and conditions of the issuance and exchange at which all persons to whom such securities will be issued have a right to appear and to whom adequate notice of the hearing has been given. The issuance of New Aptiv shares in the Scheme will fall within the exemption provided by Section 3(a)(10) of the Securities Act: (i) the New Aptiv Shares will be exchanged for the Company Shares; (ii) in determining whether it is appropriate to sanction the Scheme, the Court will consider at the Court Hearing whether the terms and conditions of the Scheme are fair to Aptiv PLC’s ordinary shareholders; (iii) the Company will advise the Court of the Company’s intent to rely on the Section 3(a)(10) exemption based on the Court’s sanction of the Scheme; (iv) the Court will hold the Court Hearing pursuant to Part 18A of the Company’s Law prior to sanctioning the Scheme and (v) all shareholders of Aptiv PLC will be given adequate notice of, and are entitled to attend and be heard at, the Court Hearing, either in person or through a Jersey advocate, to support or oppose the Scheme.

The New Aptiv Shares issued to Aptiv PLC ordinary shareholders in connection with the Transaction will be freely transferable, except for restrictions applicable under the Securities Act, as follows:

42

In computing the holding period of the New Aptiv Shares for the purpose of Rule 144(d), such persons will be permitted to “tack” the holding period of their Company Shares held prior to the Transaction Time.

Persons who may be deemed to be affiliates of Aptiv PLC and New Aptiv for these purposes generally include individuals or entities that control, are controlled by, or are under common control with, Aptiv PLC and New Aptiv, and would generally not include shareholders who are not executive officers, directors or significant shareholders of Aptiv PLC and New Aptiv.

We have not filed a registration statement with the SEC covering any resales of the New Aptiv Shares to be received by Aptiv PLC’s shareholders in connection with the Transaction. New Aptiv will file certain post-effective amendments to existing effective registration statements of Aptiv PLC concurrently with the completion of the Transaction.

Upon consummation of the Transaction, the New Aptiv Shares will be deemed to be registered under Section 12(b) of Exchange Act, by virtue of Rule 12g-3 under the Exchange Act, without the filing of any Exchange Act registration statement.

Effective Date and Transaction Time

Provided that (i) Scheme Shareholders vote in favor of the Scheme Proposal at the Court Meeting by the requisite majority; (ii) Scheme Shareholders vote in favor of the Scheme and Articles Amendment Proposal and the Merger Proposal at the Extraordinary General Meeting by the requisite majority; and (iii) the sanction of the Court is obtained, the Scheme will become effective upon our filing of the Court Order sanctioning the Scheme with the Registrar of Companies in Jersey. Various steps of the Transaction will occur effectively simultaneously at the Transaction Time, which we anticipate will be after the close of trading on the NYSE on the day the Scheme becomes effective, and before the opening of trading on the NYSE on the next business day. We currently expect to complete the Transaction in 2024.

In the event the conditions to the Transaction are not satisfied, the Transaction may be abandoned or delayed, even after approval by our shareholders and the sanction of the Court. In addition, the Transaction may be abandoned or delayed by our Board at any time prior to the Scheme becoming effective, even though the Scheme may have been adopted by our shareholders and sanctioned by the Court and all other conditions to the Transaction may have been satisfied. Please see “—Amendment, Termination or Delay.”

Management of New Aptiv

When the Reorganization is completed, the executive officers and directors of Aptiv immediately prior to the completion of the Reorganization will be the executive officers and directors of New Aptiv. The duration of the terms of office of the directors of New Aptiv, including the date on which they are next subject to reelection at an annual general meeting, will be the same as those applicable to them at that time in respect of their directorships of Aptiv.

Interests of Certain Persons in the Reorganization

No person who has been a director or executive officer of Aptiv at any time since the beginning of the last fiscal year, or any associate of any such person, has any substantial interest in the Reorganization, except for any interest arising from his or her ownership of securities of Aptiv. No such person is receiving any extra or special benefit not shared on a pro rata basis by all other holders of shares of Aptiv.

43

Required Vote; Board Recommendation

Court Meeting

Proposal to approve the Scheme: Company shareholders are being asked to vote on a proposal to approve the Scheme at the Court Meeting. As set out in full under the section entitled “Part 2—Explanatory Statement—4. Court Meeting and Extraordinary General Meeting” beginning on page 69, the Scheme Proposal requires the approval by (a) a majority in number of the Company shareholders of record as of the Voting Record Time that are present and voting (in person or by proxy) at the Court Meeting (or at any adjournment or postponement of such meeting) and (b) at least 75% of the votes cast by the Company shareholders present and voting (in person or by proxy).

The vote required to approve the Scheme Proposal at the Court Meeting is based on votes properly cast at the meeting. In accordance with Jersey law, Company shareholders will not be permitted to abstain with respect to the Scheme Proposal. Broker non-votes are not considered votes properly cast and will have no effect on such proposal.

The transaction is conditioned on approval of the Scheme at the Court Meeting.

The Board recommends that Company shareholders vote “FOR” the proposal to approve the Scheme at the Court Meeting.

Extraordinary General Meeting

The following resolutions are proposed to be voted on at the Extraordinary General Meeting:

Special Resolutions:

At the Extraordinary General Meeting, the requisite approval of each of the resolutions depends on whether it is an “ordinary resolution”, which requires the approval of at least a majority of the votes cast by the holders of Company Shares present and voting (in person or by proxy), or a “special resolution”, which requires the approval of at least two-thirds (2/3) of the votes cast by the holders of Company Shares present and voting (in person or by proxy), in each case, entitled to vote on the subject matter (provided a quorum is present). The Company Shareholder Proposals are “special resolutions” requiring approval of at least two-thirds (2/3) of the votes cast by Company shareholders present and voting (in person or by proxy) at the Extraordinary General Meeting.

The votes required to approve the Company Shareholder Proposals are based on votes properly cast at the Extraordinary General Meeting. Because abstentions and broker non-votes are not considered votes properly cast, abstentions and broker non-votes, will have no effect on the Company Shareholder Proposals.

44

A broker non-vote generally occurs when a broker, bank, trust or other nominee holding shares on your behalf does not vote on a proposal because the broker, bank, trust or other nominee has not received your voting instructions and lacks discretionary power to vote the shares. Broker non-votes, if any, will be counted for the purpose of determining whether a quorum is present at the Special Meetings.

After careful consideration, the Board has (i) approved and declared advisable the Scheme and the Merger, and (ii) declared that it is in the best interests of Company shareholders that Aptiv consummate the Scheme and the Merger.

The Board recommends that Company shareholders vote “FOR” the proposals to approve each of the resolutions.

Regulatory Matters

In August 2024, we submitted a declaration to the Committee on Foreign Investment in the United States (“CFIUS”) with respect to the Transaction. On September 6, CFIUS completed its review and determined that there are no unresolved national security concerns. On September 19, we submitted a 60-day advance notification to the Office of Defense Trade Controls Compliance pursuant to Section 122.4(b) of the International Traffic in Arms Regulations.

We are otherwise not aware of any other governmental approvals or actions that are required to complete the Transaction other than compliance with U.S. federal and state securities laws and Jersey corporate law. We do not believe that any significant regulatory approvals will be required to effect the Transaction.

No Appraisal Rights

Under Jersey law, none of the shareholders of Aptiv has any right to an appraisal of the value of their shares or payment for them in connection with the Transaction.

Exchange of Shares

Assuming the Transaction becomes effective, if you hold your Company Shares in uncertificated book-entry form or through DTC, at the Transaction Time your Company Shares will be cancelled and New Aptiv Shares will be issued without any action on your part.

If you hold Company Shares directly in certificated form and the Transaction becomes effective, soon after the Transaction Time our Transfer Agent will send you a letter of transmittal, which is to be used to surrender your Aptiv ordinary share certificates and to apply for share certificates evidencing your ownership in New Aptiv. The letter of transmittal will contain instructions explaining the procedure for surrendering Aptiv ordinary share certificates and applying for share certificates evidencing your ownership in New Aptiv. You should not return share certificates with the enclosed proxy cards.

Dividend Policy

During the year ended December 31, 2023 and the nine months ended September 30, 2024, we did not pay any cash dividends to holders of our ordinary shares. Any future payment of dividends will be determined by our Board and will depend on our consolidated financial position and results of operations and other factors deemed relevant by our Board.

Compensation and Employee Benefit Plans

The Aptiv PLC Long-Term Incentive Plan provides for the granting of various forms of equity awards, including stock options, stock appreciation rights, restricted stock units and restricted stock. Aptiv PLC currently only grants restricted stock units pursuant to the Aptiv PLC Long-Term Incentive Plan and related award agreements that are both time-vesting and performance-vesting.

45

It is anticipated that in connection with the Transaction, New Aptiv will assume the Aptiv PLC Long-Term Incentive Plan, or make other arrangements for any outstanding awards under the Aptiv PLC Long-Term Incentive Plan to be settled in New Aptiv Shares. To the extent required, the Aptiv PLC Long-Term Incentive Plan will be amended, effective from the Transaction Time, to provide that all outstanding awards relating to Company Shares will entitle the holder to purchase or receive, or receive benefits or amounts based on, as applicable, an equivalent number of New Aptiv Shares. All equity-based awards outstanding under the Aptiv PLC Long-Term Incentive Plan, which are currently restricted stock units, will otherwise generally be subject to the same terms and conditions as were applicable to such awards immediately prior to the Transaction Time. The rules of the Aptiv PLC Long-Term Incentive Plan and award agreement(s) will continue to apply.

At the Transaction Time, it is currently anticipated that the obligations of Aptiv PLC with respect to each of its employee benefit and/or compensation plans, severance plans, cash incentive plans, trusts, agreements, programs or arrangements will be assumed by New Aptiv and will be implemented and administered in the same manner and without interruption until the same are amended or otherwise lawfully altered or terminated.

Stock Exchange Listing

Company Shares are currently listed on the NYSE. There is currently no established public trading market for the New Aptiv Shares. We intend to make application so that, immediately following the Transaction Time, New Aptiv Shares will be listed on the NYSE under the symbol “APTV,” the same symbol under which the Company Shares are currently listed.

Accounting Treatment of the Transaction

Under U.S. GAAP, the Transaction represents a transaction between entities under common control. Assets and liabilities transferred between entities under common control are accounted for at cost. Accordingly, the assets and liabilities of Aptiv PLC will be reflected at their historical carrying amounts in the accounts of New Aptiv at the Transaction Time.

Treatment of Debt

There will be no material impact on our debt arrangements. In connection with the Reorganization, immediately following the effectiveness of the Transaction, Aptiv PLC will effect the Merger by merging with and into Aptiv Swiss Holdings, a wholly owned subsidiary of New Aptiv, with Aptiv Swiss Holdings surviving. In connection with the Merger, Aptiv Swiss Holdings will (i) enter into a supplemental indenture to each Indenture pursuant to which Aptiv Swiss Holdings will assume all of Aptiv PLC’s obligations under each series of Aptiv PLC’s outstanding Notes and (ii) enter into an assumption and/or supplement agreement relating to each Credit Agreement pursuant to which New Aptiv will assume all of Aptiv PLC’s obligations under each Credit Agreement as the “parent entity” thereunder. In addition, New Aptiv is expected to (i) enter into a supplemental indenture to each Indenture pursuant to which New Aptiv will guarantee the Notes and (ii) enter into a guarantee joinder relating to each Credit Agreement pursuant to which New Aptiv will guarantee the obligations under each Credit Agreement. Following the Reorganization, Aptiv Swiss Holdings will replace Aptiv PLC as an obligor under the Credit Agreements and the Notes, and New Aptiv will be a guarantor under the Credit Agreements (and will act as the “parent entity” thereunder) and the Indentures. The Reorganization is permitted under the Credit Agreements subject to satisfaction of certain conditions precedent as more particularly set forth therein, which are not expected to materially impact the Reorganization as described herein.

46

MATERIAL TAX CONSIDERATIONS

The information presented under the caption “Material U.S. Federal Income Tax Considerations” below is a discussion of the material U.S. federal income tax consequences to U.S. Holders (as defined below) of the Reorganization and of owning New Aptiv Shares received in the Transaction. The information presented under the caption “Material Jersey Tax Considerations” is a discussion of the material Jersey tax consequences of the Reorganization and of owning New Aptiv Shares received in the Transaction. The information presented under the caption “Material Irish Tax Considerations” is a discussion of the material Irish tax consequences of the Reorganization and of owning New Aptiv Shares received in the Transaction. The information presented under the caption “Material Swiss Tax Considerations” is a discussion of the material Swiss tax consequences of the Transaction and of owning New Aptiv Shares received in the Transaction.

You should consult your tax adviser regarding the applicable tax consequences to you of the Reorganization and owning New Aptiv Shares under the laws of the United States (federal, state and local), Jersey, Ireland, Switzerland and any other applicable jurisdiction.

Material U.S. Federal Income Tax Considerations

The following is a description of material U.S. federal income tax consequences of the Reorganization and of the ownership and disposition of New Aptiv Shares received in the Transaction generally applicable to U.S. Holders.

This summary is limited to U.S. federal income tax considerations relevant to U.S. Holders that hold Company Shares and, after the completion of the Transaction, will hold New Aptiv Shares, as “capital assets” within the meaning of Section 1221 of the Internal Revenue Code of 1986, as amended (the “Code”) (generally, property held for investment). This discussion does not address all aspects of U.S. federal income taxation that may be relevant to particular holders in light of their individual circumstances or status, including:

With respect to the consequences of holding New Aptiv Shares, this discussion is limited to U.S. Holders that will obtain such New Aptiv Shares by virtue of the Transaction.

47

If a partnership (or any entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds Company Shares or New Aptiv Shares, the tax treatment of such partnership and its partners will generally depend on the status of the partners, the activities of the partnership and the partner, and certain determinations made at the partner level. Partnerships holding any Company Shares or New Aptiv Shares and their partners should consult their tax adviser as to the particular U.S. federal income tax consequences of the Reorganization and the ownership and disposition of New Aptiv Shares.

This discussion is based on the Code, proposed, temporary and final Treasury regulations promulgated under the Code, judicial and administrative interpretations thereof, and the income tax treaty between the United States and Switzerland (the “Treaty”), all as of the date hereof and all of which are subject to differing interpretations. All of the foregoing are subject to change, which change could apply retroactively and could affect the tax considerations described herein. This discussion does not address alternative minimum or Medicare contribution tax considerations, the special tax accounting rules under Section 451(b) of the Code, or U.S. federal taxes other than those pertaining to U.S. federal income taxation (such as estate or gift taxes), nor does it address any aspects of U.S. state, local or non-U.S. taxation.

We have not sought and do not intend to seek any ruling from the U.S. Internal Revenue Service (the “IRS”) regarding any aspect of the Reorganization. There can be no assurance that the IRS will not take positions that are inconsistent with those discussed below or that any such IRS positions would not be sustained by a court.

As used herein, the term “U.S. Holder” means a person that is, for U.S. federal income tax purposes, a beneficial owner of Company Shares and, after the Reorganization, New Aptiv Shares and is:

THIS SUMMARY DOES NOT PURPORT TO BE A COMPREHENSIVE ANALYSIS OR DESCRIPTION OF ALL POTENTIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE REORGANIZATION OR OF THE OWNERSHIP AND DISPOSITION OF THE NEW APTIV SHARES. HOLDERS AND OWNERS OF COMPANY SHARES SHOULD CONSULT THEIR TAX ADVISER REGARDING THE PARTICULAR TAX CONSEQUENCES TO THEM OF THE REORGANIZATION AND OF THE OWNERSHIP AND DISPOSITION OF NEW APTIV SHARES AFTER THE REORGANIZATION, INCLUDING THE APPLICABILITY AND EFFECTS OF U.S. FEDERAL, STATE, LOCAL, AND NON-U.S. TAX LAWS.

Tax Consequences of the Reorganization

We have received a written opinion (“U.S. Tax Opinion”) of Sidley Austin LLP (“U.S. Tax Counsel”), dated as of the date of this Proxy Statement and subject to certain qualifications and limitations set forth therein, to the effect that the Transaction and the Merger will be treated as parts of an integrated series of transactions that will be treated for U.S. federal income tax purposes as a reorganization within the meaning of Section 368(a) of the Code (a “Section 368(a) Reorganization”), and that Aptiv PLC and New Aptiv will each be a party to the Section 368(a) Reorganization within the meaning of Section 368(b) of the Code.

In rendering the U.S. Tax Opinion, U.S. Tax Counsel has relied on (1) representations and covenants made by Aptiv PLC and New Aptiv, including those contained in the certificate of an officer of Aptiv PLC and New Aptiv, and (2) certain specified assumptions. If any of those representations or assumptions is incorrect or untrue or any of those covenants is not complied with, or if the facts upon which the U.S. Tax Opinion is based are different from the facts that prevail at the time of the closing date, the conclusions reached in the U.S. Tax Opinion and the U.S. federal income tax consequences discussed below could be adversely affected. An opinion of tax counsel neither binds the IRS nor precludes the IRS or the courts from adopting a contrary position.

48

The following discussion assumes that the Transaction and the Merger will be treated as parts of an integrated series of transactions that will qualify as a Section 368(a) Reorganization.

Tax Consequences to Aptiv PLC and New Aptiv

Neither Aptiv PLC nor New Aptiv will recognize any gain or loss for U.S. federal income tax purposes as a result of the Reorganization.

Tax Consequences to U.S. Holders

A U.S. Holder who receives New Aptiv Shares in the Transaction will not recognize any gain or loss solely as a result of the Transaction. Such U.S. Holder will have an adjusted tax basis in the New Aptiv Shares received in the Transaction equal to the adjusted tax basis of the Company Shares surrendered by that holder in the Transaction. The holding period for the New Aptiv Shares received in the Transaction will include the holding period for the Company Shares surrendered therefor. If a U.S. Holder holds Company Shares that were acquired at different times and/or for different amounts, the foregoing rules will apply separately with respect to each block of Company Shares so acquired. Under applicable Treasury regulations, a U.S. Holder will not be required to file a “gain recognition agreement” with the IRS solely as a result of the Transaction.

Consequences to U.S. Holders of the Ownership and Disposition of New Aptiv Shares

Dividends and Other Distributions on New Aptiv Shares

We do not currently expect to make distributions on New Aptiv Shares. In the event that we do make distributions of cash or other property, subject to the passive foreign investment company (“PFIC”) rules discussed below under the heading “Passive Foreign Investment Company Rules,” distributions on New Aptiv Shares will generally be taxable as a dividend for U.S. federal income tax purposes to the extent paid from New Aptiv’s current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of New Aptiv’s current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the U.S. Holder’s adjusted tax basis in its New Aptiv Shares. Any remaining excess will be treated as gain realized on the sale or other disposition of the New Aptiv Shares and will be treated as described below under the heading “—Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of New Aptiv Shares.” Because New Aptiv may not maintain calculations of earnings and profits under U.S. federal income tax principles, it is expected that the full amount of distributions (if any) paid by New Aptiv will be reported as dividends for U.S. federal income tax purposes.

Amounts treated as dividends that New Aptiv pays to a U.S. Holder that is a taxable corporation generally will be taxed at regular rates and will not qualify for the dividends received deduction generally allowed to domestic corporations in respect of dividends received from other domestic corporations. With respect to non-corporate U.S. Holders, under tax laws currently in effect and subject to certain exceptions (including, but not limited to, dividends treated as investment income for purposes of investment interest deduction limitations), dividends generally will be taxed at the lower applicable long-term capital gains rate only if (i) New Aptiv Shares are readily tradable on an established securities market in the United States or New Aptiv is eligible for the benefits of the Treaty, (ii) New Aptiv is not treated as a PFIC with respect to such U.S. Holder for the taxable year in which the dividend was paid nor for the preceding taxable year and (iii) certain holding period and other requirements are met. Company Shares are currently listed on the NYSE, and, after the Transaction, it is expected that New Aptiv Shares will be listed on the NYSE.

The amount of a dividend will include any amounts withheld by us in respect of Swiss income taxes. Dividends will be included in a U.S. Holder’s income on the date of the U.S. Holder’s receipt of the dividend.

Subject to applicable limitations, some of which vary depending upon the U.S. Holder’s particular circumstances, Swiss income taxes withheld from dividends on New Aptiv Shares (at a rate not exceeding the

49

rate provided by the Treaty) will be creditable against the U.S. Holder’s U.S. federal income tax liability. The rules governing foreign tax credits are complex and U.S. Holders should consult their tax adviser regarding the creditability of foreign taxes in their particular circumstances. In lieu of claiming a foreign tax credit, U.S. Holders may, at their election, deduct foreign taxes, including any Swiss income tax, in computing their taxable income, subject to generally applicable limitations under U.S. law. An election to deduct foreign taxes instead of claiming foreign tax credits applies to all foreign taxes paid or accrued in the taxable year.

Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of New Aptiv Shares

Subject to the PFIC rules discussed below under the heading “Passive Foreign Investment Company Rules,” upon any sale, exchange or other taxable disposition of a New Aptiv Share, a U.S. Holder generally will recognize gain or loss in an amount equal to the difference between (i) the sum of (x) the amount of the cash and (y) the fair market value of any other property, received in such sale, exchange or other taxable disposition and (ii) the U.S. Holder’s adjusted tax basis in such New Aptiv Share (determined as described herein), in each case as calculated in U.S. dollars. Any such gain or loss generally will be capital gain or loss and will be long-term capital gain or loss if the U.S. Holder’s holding period for such New Aptiv Share exceeds one year. Long-term capital gain realized by a non-corporate U.S. Holder generally will be taxable at a reduced rate. The deductibility of capital losses is subject to limitations. This gain or loss generally will be treated as U.S. source gain or loss.

Passive Foreign Investment Company Rules

Under the Code, a non-U.S. corporation will be a PFIC for any taxable year in which, after the application of certain “look-through” rules with respect to subsidiaries, either (i) 75% or more of its gross income consists of “passive income,” or (ii) 50% or more of the average quarterly value of its assets consist of assets that produce, or are held for the production of, “passive income.” For purposes of the above calculations, a non-U.S. corporation will be treated as if it holds its proportionate share of the assets of, and receives directly its proportionate share of the income of, any other corporation in which it directly or indirectly owns at least 25%, by value, of the shares of such corporation. Passive income includes, among other things, interest, dividends, rents, certain non-active royalties and capital gains.

Based on Aptiv PLC’s current operations, income, assets and certain estimates and projections, including as to the relative values of its assets, Aptiv PLC does not expect to be a PFIC for the current taxable year and it does not expect it or New Aptiv to become a PFIC in the foreseeable future.

If Aptiv PLC is or was a PFIC for any taxable year during the holding period of a U.S. Holder in its Company Shares, then New Aptiv will also be treated as a PFIC as to such U.S. Holder with respect to New Aptiv Shares received in exchange for Company Shares pursuant to the Transaction, even if New Aptiv is not a PFIC in any year, unless the U.S. Holder makes a valid deemed sale or deemed dividend election under applicable Treasury regulations.

If New Aptiv is a PFIC (or is treated as a PFIC with respect to a U.S. Holder as described above) for any taxable year (or portion thereof) that is included in the holding period of a U.S. Holder of New Aptiv Shares, gain recognized by a U.S. Holder on a sale or other disposition (including certain pledges) of New Aptiv Shares would be allocated ratably over the U.S. Holder’s holding period for such shares. The amounts allocated to the taxable year of the sale or other disposition and to any year before New Aptiv became (or is treated as having become) a PFIC would be taxed as ordinary income. The amount allocated to each other taxable year would be subject to tax at the highest rate imposed on ordinary income in effect for individuals or corporations, as appropriate, for that taxable year, and an interest charge would be imposed on the amount allocated to that taxable year. Further, to the extent that any distribution received by a U.S. Holder on its New Aptiv Shares exceeds 125% of the average of the annual distributions on the Company Shares or New Aptiv Shares, as applicable, received during the preceding three years or the U.S. Holder’s holding period, whichever is shorter, that distribution would be subject to taxation in the same manner as gain, described immediately above. Certain

50

elections may be available to a U.S. Holder which would result in different tax consequences from those described above.

In addition, if New Aptiv is a PFIC or, with respect to a particular U.S. Holder, is treated as a PFIC for the taxable year in which New Aptiv pays a dividend or for the prior taxable year, the preferential dividend rates discussed above with respect to dividends paid to non-corporate U.S. Holders would not apply.

Other PFIC Rules

If a U.S. Holder owns (or is deemed to own) New Aptiv Shares during any year in which New Aptiv is a PFIC (or is treated as a PFIC with respect to a U.S. Holder as described above), the U.S. Holder generally must file annual reports, containing such information as the U.S. Treasury may require on IRS Form 8621 (or any successor form) with respect to New Aptiv, with the U.S. Holder’s federal income tax return for that year, unless otherwise specified in the instructions with respect to such form.

U.S. HOLDERS SHOULD CONSULT THEIR TAX ADVISER CONCERNING THE APPLICATION OF THE PFIC RULES IN THEIR PARTICULAR CIRCUMSTANCES IN THE EVENT THAT EITHER OF APTIV PLC AND New Aptiv IS OR BECOMES A PFIC.

Information Reporting and Backup Withholding

Dividend payments with respect to New Aptiv Shares and proceeds from the sale or exchange of New Aptiv Shares may be subject to information reporting to the IRS and possible United States backup withholding. Backup withholding (currently at a rate of 24 percent) will not apply, however, to a U.S. Holder who furnishes a correct taxpayer identification number (generally on an IRS Form W-9 provided to the relevant paying agent) and makes other required certifications, or who is otherwise exempt from backup withholding and establishes such exempt status if required to do so. Any amounts withheld under the backup withholding rules may be allowed as a refund or credit against a holder’s U.S. federal income tax liability, if any, provided the required information is timely furnished to the IRS.

Reporting with Respect to Foreign Financial Assets

Certain U.S. Holders holding specified foreign financial assets with an aggregate value in excess of the applicable dollar thresholds are required to report information to the IRS relating to New Aptiv Shares or the non-U.S. financial accounts through which they are held, subject to certain exceptions (including an exception for New Aptiv Shares held in accounts maintained by U.S. financial institutions), by attaching a complete IRS Form 8938 (Statement of Specified Foreign Financial Assets) with their tax return for each year in which they hold New Aptiv Shares.

Material Jersey Tax Considerations

The comments set out below are intended as a general guide only to certain Jersey stamp duty and transfer tax considerations applicable to the Scheme and do not constitute tax advice. Specifically, the comments do not deal with any other Jersey tax considerations which may be relevant for Scheme Shareholders who are resident in Jersey.

Under current Jersey tax legislation, no stamp duty or other transfer tax is chargeable on the transfer of shares in a Jersey company unless such transfer conveys the right to occupy Jersey property. Therefore, no Jersey stamp duty or transfer tax is expected to be payable by Scheme Shareholders on the transfer of their Scheme Shares or on the issue of the New Aptiv Shares.

51

Material Irish Tax Considerations

This is a summary of the principal Irish tax considerations for certain beneficial owners of Company Shares who receive New Aptiv Shares under the Transaction based on Irish taxation laws and the practices of the Irish Revenue Commissioners currently in force in Ireland and may be subject to change. It only deals with Aptiv PLC shareholders who are not Irish resident and do not hold their Company Shares in connection with a branch, agency or permanent establishment in Ireland and who are not within the temporary non-Irish residence rules applicable to individuals. Particular rules not discussed below may apply to certain classes of taxpayers holding Company Shares, such as dealers in securities, collective investment schemes, insurance companies, trusts, persons who acquired or hold their Company Shares in connection with an employment that is subject to Irish employment taxes. The summary does not constitute tax or legal advice and the comments below are of a general nature only. Holders of Company Shares should consult their professional advisers on the tax implications of the Transaction under the laws of their country of residence, citizenship or domicile. If you are in doubt as to your tax position or are subject to tax in a jurisdiction other than Ireland, you should consult an appropriate professional adviser without delay.

Taxation of Chargeable Gains

Aptiv PLC shareholders should not be liable for Irish tax on chargeable gains in relation to the Transaction.

Withholding Taxes

Aptiv PLC shareholders should not be liable for Irish withholding taxes in relation to the Transaction.

Stamp Duty

No Irish stamp duty should be payable by Aptiv PLC shareholders on the Transaction.

Material Swiss Tax Considerations

The following is a description of certain material Swiss federal, cantonal and communal income and federal withholding and stamp tax consequences of the Reorganization and of the ownership and disposition of New Aptiv Shares received in the Transaction.

This discussion is not a complete analysis of all of the possible tax consequences of the Reorganization or of ownership and disposition of the Company Shares, and after the completion of the Reorganization, the New Aptiv Shares, and does not address all tax considerations that may be relevant to you. Special rules that are not discussed in the general descriptions below may also apply to you.

This discussion is based on the laws of the Confederation of Switzerland, including the Federal Income Tax Act of 1990, the Federal Harmonization of Cantonal and Communal Income Tax Act of 1990, The Federal Withholding Tax Act of 1965, the Federal Stamp Duty Act of 1973, as amended, which we refer to as the “Swiss tax law,” existing and proposed regulations promulgated thereunder, published judicial decisions and administrative pronouncements, each as in effect on the date of this Proxy Statement or with a known future effective date. These laws may change, possibly with retroactive effect.

For purposes of this discussion, a “Swiss Holder” is any beneficial owner of Company Shares, and after the completion of the Reorganization, New Aptiv Shares, that for Swiss income tax purposes is:

52

A “non-Swiss Holder” of the Company Shares, or after the completion of the Reorganization, the New Aptiv Shares, is a holder that is not a Swiss Holder. For purposes of this summary, “Holder” or “Shareholder” means either a Swiss Holder or a non-Swiss Holder or both, as the context may require.

Tax Consequences of the Reorganization

Aptiv PLC and New Aptiv Tax Consequences

Due to the expected application of certain statutory reliefs or exemptions, the Reorganization is not expected to give rise to Swiss tax for Aptiv PLC or New Aptiv under Swiss tax law. We have obtained tax rulings from competent Swiss tax authorities that the Transaction and the Merger are tax neutral from a Swiss corporate income and capital tax, Swiss withholding tax and Swiss stamp taxes perspective at the level of Aptiv PLC and New Aptiv as well as Aptiv Swiss Holdings provided that certain requirements are met.

Shareholder Tax Consequences

No Swiss tax is due for non-Swiss Holders upon the receipt of New Aptiv Shares pursuant to the Reorganization.

If Swiss Holders are beneficial owners of the Company Shares, and after the completion of the Reorganization, the New Aptiv Shares, the Reorganization may result in Swiss tax consequences to them and they are therefore urged to consult their own tax advisers.

Taxation of New Aptiv subsequent to the Reorganization

Corporate Income Tax

A Swiss tax resident company is subject to income tax at the federal, cantonal and communal levels on its worldwide income. At the federal level, a statutory corporate income tax rate of 8.5 percent applies. In Schaffhausen, the cantonal and communal corporate income tax is levied based on a multi-stage statutory tax rate of 2.7 percent on the first 5 million Swiss francs of net profit; 5.925 percent on the following 10 million Swiss francs of net profit and for net profits over 15 million Swiss francs, the standard tax rate is 4.85 percent. The cantonal and communal corporate income tax is further multiplied by a cantonal and communal multiplier. The overall (federal, cantonal, communal) effective corporate income tax rate may vary, but amounts to a maximum of approximately 15 percent in 2024, depending on the amount of taxable net profit and respective cantonal/communal multiplier. However, we will be entitled to a “participation relief” that may effectively eliminate Swiss corporate income taxation on dividend income from qualifying subsidiaries and on capital gains on the disposal of qualifying participations in subsidiaries.

As of January 1, 2024, Switzerland introduced a Qualified Domestic Minimum Top-Up Tax (“QDMMT”) based on OECD Pillar II-rules. The QDMTT may be characterized as an additional federal corporate income tax sui generis for Swiss entities of an in-scope multinational enterprise (i.e., “MNE” with an annual consolidated revenue in excess of EUR 750 million). The QDMTT will be determined in line with the OECD GloBE Model Rules and on a jurisdictional level (jurisdictional blending). Generally, the QDMTT is levied if the tax rate of Swiss entities of an in-scope MNE, calculated on the basis of the specific GloBe tax base and the so-called “covered taxes”, does not reach the minimum corporate tax rate of 15%. In such case, the QDMTT should bring the tax rate up to 15%.

53

Corporate Capital Tax

As a Swiss tax resident company, New Aptiv is subject to an annual capital tax which is levied at the cantonal and communal level only. The effective capital tax rate in Schaffhausen is 0.00475 percent (2024 basis).

Withholding Tax on Dividend Payments

Dividend payments made by New Aptiv are subject to a 35% Swiss withholding tax deductible from the gross dividend payment. Such withholding tax may be reducible / fully or partially refundable for certain shareholders depending on an applicable double taxation treaty or for Swiss resident shareholders under Swiss national tax laws.

Issuance Stamp Tax

Swiss issuance stamp tax is a federal tax levied on the issuance of shares and increases in the equity of Swiss corporations. Furthermore, a foreign corporation with Swiss tax residency may opt to be equally subject to Swiss issuance stamp tax in order to benefit also from a domestic treatment with regard to the reclaim procedure of Swiss withholding tax. Thus, New Aptiv will opt to be subject to the issuance stamp tax. The applicable tax rate is 1% of the newly issued capital or the fair market value of the assets contributed to equity. Exemptions are available in particular relating to qualifying restructuring transactions. As a result, any future issuance of shares by New Aptiv or contribution in New Aptiv’s equity may be subject to issuance stamp tax unless the shares are issued or the equity is contributed in the context of a qualifying restructuring transaction.

Securities Transfer Stamp Tax

The transfer of taxable Swiss and foreign securities (e.g., shares) in which a Swiss bank or other Swiss securities dealers (as defined in the Swiss Federal Stamp Tax Act) participate as contracting parties or as intermediary is typically subject to Swiss transfer tax at the rate of 0.15% (for securities issued by a Swiss resident) and 0.3% (for securities issued by a non-Swiss resident). However, the transfer of taxable securities within qualifying restructuring transactions is exempt from transfer stamp tax. After the Reorganization, New Aptiv will qualify as securities dealer and will be subject to transfer stamp tax after a period of six months after the end of its first financial year after the Reorganization.

Consequences to Shareholders of New Aptiv subsequent to the Reorganization

The tax consequences discussed below are not a complete analysis or listing of all the possible tax consequences that may be relevant to you. You should consult your own tax advisor in respect of the tax consequences related to receipt, ownership, purchase or sale or other disposition of New Aptiv Shares and the procedures for claiming a refund of Swiss withholding tax.

Swiss Income Tax on Dividends and Similar Distributions

A Swiss Holder is required to include dividends and similar distributions in his income tax return and is liable for Swiss income taxes on any net taxable income according to general rules. Various deductions and exemptions may apply. Therefore Swiss Holders are urged to contact their tax advisors.

A non-Swiss Holder will generally not be subject to Swiss income taxes on dividend income and similar distributions in respect of New Aptiv Shares, unless the Shares are attributable to a permanent establishment or a fixed place of business maintained in Switzerland by such non-Swiss Holder. However, dividends and similar distributions may be subject to Swiss withholding tax. See “—Swiss Withholding Tax—Distributions to Shareholders.”

54

Swiss Income Tax on Capital Gains upon Disposal of New Aptiv Shares

A Swiss Holder might be subject to Swiss taxation on capital gains on the disposal of shares according to general rules. Various deductions and exemptions may apply. Swiss Holders are therefore urged to contact their tax advisors.

A non-Swiss Holder will not be subject to Swiss income taxes for capital gains unless the Holder’s shares are attributable to a permanent establishment or a fixed place of business maintained in Switzerland by such non-Swiss Holder. In such case, the non-Swiss Holder is required to recognize capital gains or losses on the sale of such shares, which will be subject to cantonal, communal and federal income tax as required under the relevant tax laws and urged to contact their tax advisors.

Swiss Wealth and Capital Tax

Swiss Holder need to include the New Aptiv Shares in their net asset basis that is subject to annual Swiss wealth (individuals) or capital (corporations) tax according to general rules.

A non-Swiss Holder will not be subject to Swiss wealth or capital taxes unless the Holder’s New Aptiv Shares are attributable to a permanent establishment or a fixed place of business maintained in Switzerland by such non-Swiss Holder.

Swiss Withholding Tax—Distributions to Shareholders

A withholding tax of 35% is due on dividends and similar distributions to New Aptiv Shareholders from New Aptiv, regardless of the place of residency of the shareholder (subject to exceptions discussed under “—Exemption from Swiss Withholding Tax—Distributions to Shareholder” below). New Aptiv will be required to withhold at such rate and remit on a net basis any payments made to a Holder of New Aptiv Shares and pay such withheld amounts to the Swiss federal tax administration. Please see “—Refund of Swiss Withholding Tax on Dividends and Similar Distributions”.

Exemptions from Swiss Withholding Tax—Distributions to Shareholders

Distributions to shareholders based upon a reduction of the nominal share capital and distributions paid out of qualifying reserves of capital contributions (“Reserven aus Kapitaleinlagen”) are generally not subject to Swiss federal withholding tax.

New Aptiv obtained a tax ruling from competent Swiss federal tax authority that the Transaction will allow for creation of qualifying reserves from capital contributions (“Reserven aus Kapitaleinlagen”). New Aptiv expects to create qualifying capital contribution reserves in an amount equal to approximately $30 billion at the New Aptiv level (which would be subject to formal confirmation by the Swiss federal tax authority after the completion of the Transaction) that are exempt from Swiss dividend withholding tax upon distribution. New Aptiv expects to pay distributions out of such reserves, and as a result, any such distributions to shareholders would be exempt from the Swiss withholding tax. However, the amount of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”) may be depleted over time as New Aptiv uses such reserves for distributions to shareholders or share repurchases.

Swiss Withholding Tax—Repurchase of Shares

Repurchases of shares for the purposes of capital reduction are treated as a partial liquidation subject to the 35% Swiss withholding tax, regardless of the place of residency of the shareholder. The amount subject to the Swiss withholding tax is the difference between the purchase price paid by New Aptiv and the nominal value of such Shares to the extent such amount is not booked against reserves of capital contributions (“Reserven aus

55

Kapitaleinlagen”). In a tax ruling obtained by New Aptiv, the competent Swiss federal tax authority confirmed that the Transaction will allow for the creation of such qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”). New Aptiv expects to create qualifying capital contribution reserves in an amount equal to approximately $30 billion at the New Aptiv level (which would be subject to formal confirmation by the Swiss federal tax authority after the completion of the Transaction). New Aptiv expects to book the difference between the purchase price paid by New Aptiv and the nominal value of repurchased shares against reserves of qualified capital contributions (“Reserven aus Kapitaleinlagen”), and as a result, any such repurchase of shares from shareholders would not be subject to Swiss withholding tax. However, the amount of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”) may be depleted over time as New Aptiv uses such reserves for distributions to shareholders or share repurchases.

The repurchase of shares for purposes other than qualifying capital reduction, such as to retain as treasury shares for use in connection with stock incentive plans, convertible debt or other instruments within certain periods, will generally not be subject to Swiss withholding tax provided the threshold of 10% (or, in certain cases, 20%) of the registered share capital as required by the Swiss Code of Obligation is satisfied and the shares are resold within certain periods prescribed by Swiss law. If New Aptiv purchases its own shares in order to hold them in treasury, it must present the acquired shares on its standalone “statutory” balance sheet as a negative item in its equity. To the extent such negative item is not explicitly allocated to the reserves of capital contributions (“Reserven aus Kapitaleinlagen”) upon acquisition, the Swiss federal withholding tax is due on the difference between the purchase price paid by New Aptiv and the nominal value of such shares to the extent the treasury shares (i) are not within the admissible corporate law thresholds on treasury shares or (ii) the maximum permissible holding period prescribed by Swiss law is exceeded. New Aptiv expects to allocate the negative item against reserves of qualified capital contributions (“Reserven aus Kapitaleinlagen”), and as a result, any such repurchase of shares from shareholders would not be subject to Swiss withholding tax to the extent the treasury shares (i) are not within the admissible corporate law thresholds on treasury shares or (ii) the maximum permissible holding period prescribed by Swiss law is exceeded. However, the amount of qualifying capital contribution reserves (“Reserven aus Kapitaleinlagen”) may be depleted over time as New Aptiv uses such reserves for distributions to shareholders or share repurchases.

In most instances, Swiss companies listed on the SIX Swiss Exchange (“SIX”) carry out share repurchase programs through a “second trading line” on the SIX. Swiss institutional investors typically purchase shares from shareholders on the open market and then sell the shares on this second trading line back to the company. The Swiss institutional investors are generally able to receive a full refund of the withholding tax. Due to, among other things, the time delay between the sale to the company and the institutional investors’ receipt of the refund, the price companies pay to repurchase their shares has historically been slightly higher than the price of such companies’ shares in ordinary trading on the SIX first trading line.

We will not be able to use the SIX second trading line process to repurchase our voting shares or non-voting participation certificates because we do not intend to list our shares on the SIX. We do, however, intend to follow alternative processes to manage Swiss withholding, including the utilization of capital contribution reserves or other established non-SIX secondary line of trading structures, which we expect would enable us to repurchase our shares in a manner that should allow Swiss institutional market participants selling the shares to us to receive a refund of the Swiss withholding tax and, therefore, accomplish the same purpose as share repurchases on the second trading line at substantially the same cost to us and such market participants as share repurchases on a second trading line.

With respect to the refund of Swiss withholding tax from the repurchase of shares, see “—Refund of Swiss Withholding Tax on Dividends and Similar Distributions” below.

Refund of Swiss Withholding Tax on Dividends and Similar Distributions

Swiss Holders. A Swiss tax resident, corporate or individual, can recover the withholding tax in full if such resident is the beneficial owner of the New Aptiv Shares at the time the dividend or similar distribution becomes

56

due and provided that such resident reports the gross distribution on such resident’s income tax return, or in case of a corporation, includes the taxable income in such resident’s income statement.

Non-Swiss Holders. If the shareholder that receives a distribution from New Aptiv is not a Swiss tax resident, does not hold the shares in connection with a permanent establishment or a fixed place of business maintained in Switzerland, and resides in a country that has concluded a treaty for the avoidance of double taxation with Switzerland for which the conditions for the application and protection of and by the treaty are met, then the shareholder may be entitled to a full or partial refund of the withholding tax described above. The procedures for claiming treaty refunds (and the time frame required for obtaining a refund) may differ from country to country. Subject to specific provisions of a treaty for the avoidance of double taxation or relevant implementing provisions, the applicable refund request form may be filed with the Swiss Federal Tax Administration following receipt of the dividend or similar distribution and the relevant deduction certificate no later than December 31 of the third year following the calendar year in which the dividend was payable.

Switzerland has entered into bilateral treaties for the avoidance of double taxation with respect to income taxes with numerous countries, including the United States, whereby under certain circumstances all or part of the withholding tax may be refunded.

U.S. Residents. The Swiss-U.S. tax treaty provides that U.S. residents eligible for benefits under the treaty can seek a refund of the Swiss withholding tax on dividends for the portion exceeding 15% (leading to a refund of 20%), for the portion exceeding 5% (leading to a refund of 30% for qualifying corporate shareholders holding at least 10% of the voting stock of the dividend paying corporation) or a full refund in the case of qualified pension funds. Please refer to the discussion under “Consequences to U.S. Holders of the Ownership and Disposition of New Aptiv Shares—Dividends and Other Distributions on New Aptiv Shares” for applicability of U.S. foreign tax credits.

As a general rule, the refund will be granted under the treaty if the U.S. resident can show evidence of:

The claim for refund must be filed with the Swiss federal tax administration (Eigerstrasse 65, 3003 Berne, Switzerland), no later than December 31 of the third year following the year in which the dividend payments became due. The relevant Swiss tax form is Form 82C for companies, 82E for other entities, 82I for individuals and 82 R for regulated investment companies (RICs). These forms can be obtained from any Swiss Consulate General in the United States or from the Swiss federal tax administration. Each form needs to be filled out in triplicate, with each copy duly completed and signed before a notary public in the United States. You must also include evidence that the withholding tax was withheld at the source.

Securities Transfer Stamp Tax.

The purchase or sale of New Aptiv Shares may be subject to Swiss securities transfer stamp taxes on the transfer of taxable securities irrespective of the place of residency of the purchaser or seller if the transaction takes place through or with a Swiss bank or other Swiss securities dealer, as those terms are defined in the Swiss Federal Stamp Tax Act and no exemption applies in the specific case. If a purchase or sale is not entered into through or with a Swiss bank or other Swiss securities dealer, then no stamp tax will be due. The applicable stamp tax rate is 0.15% (for securities issued by a Swiss resident) or 0.3% (for securities issued by a foreign resident) on the purchase price or sales proceeds. If the transaction does not involve cash consideration, the transfer stamp duty is computed on the basis of the market value of the consideration. New Aptiv will qualify as

57

a securities dealer and will be subject to transfer stamp tax after a period of six months after the end of the first financial year after the Reorganization.

International Automatic Exchange of Information in Tax Matters

Switzerland has concluded an agreement with the EU on the automatic exchange of information (“AEOI”) in tax matters (the “AEOI Agreement”). This AEOI Agreement entered into force as of January 1, 2017 and applies to all member states. Furthermore, on January 1, 2017, the multilateral competent authority agreement on the automatic exchange of financial account information and, based on such agreement, a number of bilateral AEOI agreements with other jurisdictions entered into force. Based on the AEOI Agreement and other bilateral AEOI agreements and the implementing laws of Switzerland, Switzerland collects data in respect of financial assets, which may include New Aptiv Shares, held in, and income derived thereon and credited to, accounts or deposits with a paying agent in Switzerland for the benefit of individuals resident in a EU member state or in a treaty state since 2017, and exchanges it since 2018. Switzerland has signed and is expected to sign AEOI agreements with other countries. A list of such agreements of Switzerland in effect or signed and becoming effective can be found on the website of the State Secretariat for International Finance.

Swiss Facilitation of the Implementation of the U.S. Foreign Account Tax Compliance Act

Switzerland has concluded an intergovernmental agreement with the U.S. to facilitate the implementation of the Foreign Account Tax Compliance Act (FATCA). The agreement ensures that the accounts held by U.S. persons with Swiss financial institutions are disclosed to the U.S. tax authorities either with the consent of the account holder or by means of group requests within the scope of administrative assistance. Information will not be transferred automatically in the absence of consent, and instead will be exchanged only within the scope of administrative assistance on the basis of the double taxation agreement between the U.S. and Switzerland. On October 8, 2014, the Swiss Federal Council approved a mandate for negotiations with the U.S. on changing the current direct-notification-based regime to a regime where the relevant information is sent to the Swiss Federal Tax Administration, which in turn provides the information to the U.S. tax authorities. Such negotiations have been concluded on June 27, 2024 and it is expected that the new regime shall enter into force as of January 1, 2027.

THE SWISS TAX CONSIDERATIONS SUMMARIZED ABOVE ARE FOR GENERAL INFORMATION ONLY. EACH NEW APTIV SHAREHOLDER SHOULD CONSULT HIS OR HER TAX ADVISOR AS TO THE PARTICULAR CONSEQUENCES THAT MAY APPLY TO SUCH SHAREHOLDER.

58

DESCRIPTION OF NEW APTIV SHARES

The following description of New Aptiv’s share capital is a summary. This summary is not complete and is subject to the complete text of New Aptiv’s forms of Memorandum and Articles of Association attached as Annex A to this Proxy Statement. We encourage you to read those documents and laws carefully. There are differences between Aptiv PLC’s Memorandum and Articles of Association and New Aptiv’s Memorandum and Articles of Association as they will be in effect after the Transaction relating to modification of any rights that attach to a specific class of shares, such as voting or dividend rights. Rights of shareholders of New Aptiv will be substantially identical to the rights of current shareholders of Aptiv PLC. See “Rights of Shareholders and Powers of the Board of Directors.” Except where otherwise indicated, the description below reflects New Aptiv’s Memorandum and Articles of Association as those documents will be in effect upon completion of the Transaction. As used below in this Description of New Aptiv Shares, the terms “Aptiv,” the “Company,” “we,” “us,” and “our” refer to New Aptiv.

As of October 31, 2024, there were 235,035,739 ordinary shares of Aptiv PLC issued and outstanding. In the Transaction, New Aptiv will issue Company Shares on a one-for-one basis to holders of ordinary shares of Aptiv PLC, and all previously outstanding Company Shares, which prior to the Transaction Time will be held by Aptiv PLC, will be repurchased and cancelled by New Aptiv. As a result, the number of Company Shares issued and outstanding immediately following the Transaction will be equal to the number of ordinary shares of Aptiv PLC issued and outstanding immediately prior to the Transaction. All outstanding Company Shares are validly issued, fully paid and non-assessable. The Company Shares do not have preemptive, subscription or redemption rights. Neither our Memorandum of Association or Articles of Association nor the laws of Jersey restrict in any way the ownership or voting of Company Shares held by non-residents of Jersey.

Dividend and Liquidation Rights. Holders of Company Shares are entitled to receive equally, share for share, any dividends that may be declared in respect of our Company Shares by the Board of Directors out of funds legally available therefor. If, in the future, we declare cash dividends, such dividends will be payable in U.S. dollars. In the event of our liquidation, after satisfaction of liabilities to creditors, holders of Company Shares are entitled to share pro rata in our net assets. Such rights may be affected by the grant of preferential dividend or distribution rights to the holders of a class or series of preferred shares that may be authorized in the future. Our Board of Directors has the power to declare such interim dividends as it determines. Declaration of a final dividend (not exceeding the amounts proposed by our Board of Directors) requires shareholder approval by adoption of an ordinary resolution. Failure to obtain such shareholder approval does not affect previously paid interim dividends.

Voting, Shareholder Meetings and Resolutions. Holders of Company Shares have one vote for each ordinary share held on all matters submitted to a vote of holders of Company Shares. These voting rights may be affected by the grant of any special voting rights to the holders of a class or series of preferred shares that may be authorized in the future. Pursuant to Jersey law, an annual general meeting shall be held once every calendar year at the time (within a period of not more than 18 months after the last preceding annual general meeting) and at the place as may be determined by the Board of Directors. The quorum required for an ordinary meeting of shareholders consists of shareholders present in person or by proxy who hold or represent between them a majority of the outstanding shares entitled to vote at such meeting.

An ordinary resolution (such as a resolution for the declaration of dividends) requires approval by the holders of a majority of the voting rights represented at a meeting, in person or by proxy, and voting thereon.

Amendments to Governing Documents. A special resolution (such as, for example, a resolution amending our Memorandum of Association or Articles of Association or approving any change in authorized capitalization, or a liquidation or winding-up) requires approval of the holders of two-thirds of the voting rights represented at the meeting, in person or by proxy, and voting thereon. A special resolution can only be considered if shareholders receive at least fourteen days’ prior notice of the meeting at which such resolution will be considered.

59

Requirements for Advance Notification of Shareholder Nominations and Proposals. New Aptiv’s Articles of Association establish advance notice and related procedures with respect to shareholder proposals and nomination of candidates for election as directors.

Limits on Written Consents. Any action required or permitted to be taken by the shareholders must be effected at a duly called annual or special meeting of shareholders and may not be effected by any consent in writing in lieu of a meeting of such shareholders.

Transfer of Shares and Notices. Fully paid Company Shares are issued in registered form and may be freely transferred pursuant to the articles of association unless the transfer is restricted by applicable securities laws or prohibited by another instrument. Each shareholder of record is entitled to receive at least fourteen days’ prior notice (excluding the day of notice and the day of the meeting) of an ordinary shareholders’ meeting and of any shareholders’ meeting at which a special resolution is to be adopted. For the purposes of determining the shareholders entitled to notice and to vote at the meeting, the Board of Directors may fix a date as the date for any such determination.

Modification of Class Rights. The rights attached to any class (unless otherwise provided by the terms of issue of that class), such as voting, dividends and the like, may be varied with the sanction of an ordinary resolution passed at a separate general meeting of the holders of the shares of that class.

Election and Removal of Directors. The Company Shares do not have cumulative voting rights in the election of directors. As a result, the holders of Company Shares that represent more than 50% of the voting power have the power to elect any of our directors who are up for election. All of our directors will be elected at each annual meeting.

Immediately following the Transaction, the directors of Aptiv PLC immediately prior to the Transaction Time will become the directors of the Company, and all of the directors of the Company immediately prior to the Transaction Time shall step down. As such, immediately following the Transaction Time, our Board of Directors is expected to consist of the 10 directors who currently serve on the board of Aptiv PLC. Our Articles of Association state that shareholders may only remove a director for cause. Our Board of Directors has sole power to fill any vacancy occurring as a result of the death, disability, removal or resignation of a director or as a result of an increase in the size of the Board of Directors.

Applicability of U.K. Takeover Code. We do not believe that the U.K. City Code on Takeovers and Mergers will apply to takeover transactions for the Company.

Listing. Following the Transaction, New Aptiv’s Shares will be listed on the NYSE under the symbol “APTV.”

Transfer Agent and Registrar. The U.S. transfer agent and registrar for the Company Shares is Computershare Trust Company, N.A. The U.S. transfer agent and registrar’s address is 250 Royall Street, Canton, MA 02021, Attention: Client Administration. Computershare Investor Services (Jersey) Limited is the transfer agent and registrar for the Company Shares in Jersey and its address is 13 Castle Street, St. Helier, JE1 1ES, Jersey.

60

RIGHTS OF SHAREHOLDERS

AND POWERS OF THE BOARD OF DIRECTORS

Your rights as a shareholder of Aptiv PLC and the relative powers of the Board are governed by Jersey law and Aptiv PLC’s Memorandum and Articles of Association. After the Transaction, you will become a shareholder of New Aptiv, and your rights and the relative powers of New Aptiv’s board of directors will remain governed by Jersey law and New Aptiv’s Memorandum and Articles of Association as they will be in effect after the Transaction.

Your rights as a shareholder of New Aptiv and the relative powers of the board of directors will continue to be governed by Jersey law. Except as described below with respect to modification of any rights that attach to a specific class of shares, such as voting or dividend rights, your rights as a shareholder of New Aptiv’s Shares after the Reorganization will be identical to your rights as a shareholder of Company Shares. See “Description of New Aptiv Shares” and Annex A.

Modification of Class Rights

New Aptiv’s Memorandum and Articles of Association will permit rights attaching to any class of shares, such as voting rights and dividend rights, to be modified by an ordinary resolution, which requires the approval of at least a majority of the votes cast by shareholders present and voting, passed at a meeting of the holders of shares of that class. Currently, modification of any rights, such as voting or dividend rights, that attach to a specific class of shares under Aptiv PLC’s Memorandum and Articles of Association require a special resolution, which requires the approval of at least two-thirds of the votes cast by shareholders present and voting, passed at a meeting of the holders of shares of that class.

61

LEGAL MATTERS

Davis Polk & Wardwell LLP will advise the Company on the Transaction. Sidley Austin LLP will pass upon certain U.S. federal income tax consequences of the Transaction. Lenz  & Staehelin will pass upon certain Swiss tax consequences of the Transaction.

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires the Company’s directors, officers, and beneficial owners of more than 10% of the Company’s common shares (collectively, “Reporting Persons”) to file with the SEC initial reports of ownership and reports of changes in ownership of common shares of the Company. Such Reporting Persons are required by SEC regulation to furnish the Company with copies of all Section 16(a) reports they file. Based on its review of the copies of such filings received by it with respect to the year ended December 31, 2023, the Company believes that all required persons complied with all Section  16(a) filing requirements.

SHAREHOLDER PROPOSALS FOR THE 2025 ANNUAL MEETING

Shareholder Proposals in the Proxy Statement. Rule 14a-8 under the Exchange Act addresses when a company must include a shareholder’s proposal in its proxy statement and identify the proposal in its form of proxy card when the company holds an annual or special meeting of shareholders. Under Rule 14a-8, in order for your proposals to be considered for inclusion in the proxy statement and proxy card relating to our 2025 annual general meeting, your proposals must be sent to New Aptiv at Spitalstrasse 5, 8200 Schaffhausen, Switzerland, Attention: Corporate Secretary, if the Transaction has become effective, or, if the Transaction has not become effective, Aptiv PLC at 5 Hanover Quay, Grand Canal Dock, Dublin, D02 VY79, Ireland, Attention: Corporate Secretary, not less than 120 days prior to the anniversary date of the notice convening Aptiv PLC’s 2024 Annual Meeting. Therefore, the deadline is expected to be November 11, 2024 for the 2025 annual general meeting. However, if the date of the 2025 annual general meeting changes by more than 30 days from the anniversary of the 2024 Annual Meeting (for purposes of determining the deadline for the 2025 annual general meeting, the last annual general meeting of Aptiv PLC), the deadline is a reasonable time before we begin to print and mail our proxy materials. We will notify you of this deadline in a Quarterly Report on Form 10-Q or in another communication to you. Shareholder proposals must also be otherwise eligible for inclusion.

Shareholder Proposals and Nominations for Directors to Be Presented at Meetings. If you desire to bring a matter before an annual general meeting and the proposal is submitted outside the process of Rule 14a-8, you must follow the procedures set forth in New Aptiv’s Memorandum and Articles of Association, if the Transaction has become effective, or Aptiv PLC’s Memorandum and Articles of Association, if the Transaction has not become effective. The process under both New Aptiv and Aptiv PLC Memorandum and Articles of Association are the same, other than the address to send notice.

New Aptiv

For a shareholder to make a formal nomination for election to the Board of New Aptiv at an annual meeting, the shareholder must provide advance notice to the Company. In accordance with the procedures in New Aptiv’s Memorandum and Articles of Association, shareholders holding at least 10% of the Company Shares outstanding and who have the right to vote at general meetings of the Company may formally propose nominees for election to the Board at the next annual meeting by giving timely written notice to the Corporate Secretary at New Aptiv, Spitalstrasse 5, 8200 Schaffhausen, Switzerland. The notice periods may change in accordance with the procedures set out in Aptiv PLC’s Memorandum and Articles of Association. Any such notice must include all information regarding the proposed nominee that is required to be disclosed in a proxy statement or other filings in a contested election pursuant to Regulation 14(a) under the Exchange Act and a written and signed consent of the proposed nominee to be named in the proxy statement as a nominee and to serve as a director.

62

Aptiv PLC

For a shareholder to make a formal nomination for election to the Board of Aptiv PLC at an annual meeting, the shareholder must provide advance notice to the Company. In accordance with the procedures in Aptiv PLC’s Memorandum and Articles of Association, shareholders holding at least 10% of the Company Shares outstanding and who have the right to vote at general meetings of the Company may formally propose nominees for election to the Board at the next annual meeting by giving timely written notice to the Corporate Secretary at Aptiv PLC, 5 Hanover Quay, Grand Canal Dock, Dublin, D02 VY79, Ireland. The notice periods may change in accordance with the procedures set out in Aptiv PLC’s Memorandum and Articles of Association. Any such notice must include all information regarding the proposed nominee that is required to be disclosed in a proxy statement or other filings in a contested election pursuant to Regulation 14(a) under the Exchange Act and a written and signed consent of the proposed nominee to be named in the proxy statement as a nominee and to serve as a director.

EXPENSES AND SOLICITATION

We will pay the cost for soliciting proxies for the Special Meetings. Aptiv will distribute proxy materials and follow-up reminders by mail and electronic means. We have engaged Innisfree to assist with the solicitation of proxies. We expect to pay Innisfree an aggregate fee, including reasonable out-of-pocket expenses, of $45,000, depending on the level of services actually provided. Certain Aptiv employees, officers and directors may also solicit proxies by mail, telephone or personal visits but they will not receive any additional compensation for their services.

We will also reimburse brokers, banks and other nominees for their expenses in forwarding proxy materials to beneficial owners.

HOUSEHOLDING

Only one copy of this Proxy Statement has been sent to multiple shareholders who share the same address and last name, unless we have received contrary instructions from one or more of those shareholders. This procedure is referred to as “householding.” We have been notified that certain intermediaries (brokers or banks) will also household proxy materials. We will deliver promptly, upon oral or written request, separate copies of the Proxy Statement to any shareholder at the same address. If you wish to receive separate copies or if you do not wish to participate in householding in the future, you may write to our Corporate Secretary at Aptiv PLC, 5 Hanover Quay, Grand Canal Dock, Dublin 2, Ireland D02 VY79, or call (248) 813-3005. You may contact your broker or bank to make a similar request. Shareholders sharing an address who now receive multiple copies of this Proxy Statement may request delivery of a single copy of each document by writing or calling us at the address or telephone number above or by contacting their broker or bank (provided the broker or bank has determined to household proxy materials).

OTHER BUSINESS

Matters other than those set forth in the notice thereof may not be brought before the Special Meetings.

Even if you are a holder of record who plans to attend the Special Meetings in person, please sign, date and return the enclosed proxy cards promptly or vote in accordance with the instructions listed on the proxy card. A postage-paid return-addressed envelope is enclosed for your convenience. Your cooperation in giving this matter your immediate attention and in returning your proxy will be appreciated.

63

OWNERSHIP OF CERTAIN BENEFICIAL OWNERS

Set forth in the table below is information about the number of Company Shares held by persons (including any “group” as that term is used in Section 13(d)(3) of the Exchange Act), we know to be the beneficial owners of more than 5% of Company Shares (based on 235,035,739 Company Shares outstanding at October 28, 2024), based on information furnished by the identified persons to the SEC.

The definition of beneficial ownership for proxy statement purposes includes shares over which a person has sole or shared voting power or dispositive power, whether or not a person has any economic interest in the shares. The definition also includes shares that a person has a right to acquire as of the time such information was furnished by the identified persons to the SEC or within 60 days thereof.

64

SECURITY OWNERSHIP OF MANAGEMENT AND DIRECTORS

The following table sets forth information as of October 28, 2024 concerning beneficial ownership of Company Shares by each director and each of the executive officers. The definition of beneficial ownership for proxy statement purposes includes shares over which a person has sole or shared voting power or dispositive power, whether or not a person has any economic interest in the shares. The definition also includes shares that a person has the right to acquire currently or within 60 days of October 28, 2024. Except as otherwise indicated and subject to applicable community property laws, each owner has sole voting and dispositive power with respect to the securities listed.

65

WHERE YOU CAN FIND MORE INFORMATION

We are required to file annual, quarterly and current reports, proxy statements and other information with the SEC. Statements contained in this Proxy Statement as to the contents of any contract or other document referred to are not necessarily complete and in each instance, if such contract or document is filed as an exhibit to the Annual Report, reference is made to the copy of such contract or other document filed as an exhibit to the Annual Report, each statement being qualified in all respects by such reference. A copy of the Annual Report, including the exhibits and schedules thereto, may be read and copied at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains an Internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC. The address of that site is http://www.sec.gov. We also maintain an Internet site at aptiv.com. We make available on our Internet website free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as soon as practicable after we electronically file such reports with the SEC. Our website and the information contained therein or connected thereto shall not be deemed to be incorporated into this Proxy Statement.

Aptiv PLC incorporates by reference the documents listed below and any filings Aptiv PLC will make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (excluding any information “furnished” but not “filed”) following the date of this document, but prior to the date of the meetings. The documents incorporated by reference are:

66

Important Notice Regarding the Availability of Proxy Materials for the Special Meetings to be held on December 2, 2024

The SEC has adopted rules to allow proxy materials to be posted on the Internet and to provide only a Notice of Internet Availability of Proxy Materials to shareholders. For this Proxy Statement, the Company has chosen to follow the SEC’s full set delivery option, and therefore, although we are posting this Proxy Statement online, we are also mailing a full set of our proxy materials to the Company’s shareholders. The proxy materials, including this Proxy Statement, are available at www.proxyvote.com.

67

PART 2 – EXPLANATORY STATEMENT

The following section of this Proxy Statement explains, among other things, the effect of the Scheme (as defined below) and, together with the further information contained elsewhere in this Proxy Statement, constitutes the explanatory statement in respect of the Scheme as required by Article 126 of the Companies (Jersey) Law 1991. Accordingly, in addition to the information contained in the following section of this Proxy Statement, your attention is drawn to the further information contained elsewhere in this Proxy Statement and you are advised to read this Proxy Statement in full.

It is proposed that Aptiv establish a new publicly listed parent company, New Aptiv, a Jersey company which will be resident for tax purposes in Switzerland. This will be achieved by way of court sanctioned scheme of arrangement (the “Scheme”) under Part 18A of the Companies (Jersey) Law 1991 (as amended, modified, or re-enacted from time to time, the “Companies Law”). As a result of the Scheme, Aptiv PLC will become a wholly owned subsidiary of New Aptiv.

Subject to and conditional upon the Scheme becoming effective, the board of directors of Aptiv PLC has unanimously approved the merger (the “Merger”) of Aptiv Swiss Holdings Limited (“Aptiv Swiss Holdings” or “Merger Sub”), a newly formed Jersey incorporated private limited company and direct, wholly owned subsidiary of New Aptiv, with and into Aptiv PLC, with Merger Sub surviving the Merger as a direct, wholly owned subsidiary of New Aptiv and Aptiv PLC ceasing to exist, and on the terms of and subject to the conditions of the merger agreement, dated as of November 4, 2024, by and among New Aptiv, Merger Sub and Aptiv PLC (as it may be amended from time to time, the “Merger Agreement”) which contains, among other things, the terms and means of effecting a proposed merger of Aptiv PLC and Merger Sub under Part 18B (Mergers) of the Companies Law, as more fully described elsewhere in this Proxy Statement.

Capitalized terms used but not defined in this “Part 2 – Explanatory Statement” or in the preceding portion of this Proxy Statement have the meanings ascribed to such terms in “Part 3 – The Scheme of Arrangement”.

Your attention is drawn to the sections of this Proxy Statement captioned “Recommendation of the Board” and “Background and Reasons for the Reorganization” beginning on pages 33 and 37, respectively, which set forth certain reasons (not intended to be exhaustive and may not include all of the factors considered by the Board) why the Board (i) unanimously approved and declared advisable the Transaction, the Scheme and the Merger (including the consummation of the transactions contemplated by such Transaction, the Scheme and the Merger), (ii) declared that it was in the best interests of the Company’s shareholders that the Company participate in the Transaction and consummate such transactions contemplated by such Transaction, the Scheme and the Merger, and (iii) recommend that the Company’s shareholders vote in favor of the Transaction, which would in part be made by way of the Scheme at the Court Meeting and in favor of the resolutions at the Extraordinary General Meeting (as defined below).

The Transaction involves several steps, part of which is being implemented by means of the Court-sanctioned Scheme between Aptiv and the Scheme Shareholders, under Part 18A of the Companies Law. Implementation of the Scheme requires approval of the Scheme by the Scheme Shareholders at the Court Meeting and the passing of the proposed resolutions at the extraordinary general meeting being held in connection with the Scheme (the “Extraordinary General Meeting”). The Scheme also requires the sanction of the Court. The Scheme is set out in full in Part 3 of this Proxy Statement titled “The Scheme of Arrangement”.

The purpose of the Scheme is to provide for New Aptiv to acquire the entire issued and to be issued ordinary share capital of Aptiv. This is to be achieved by New Aptiv acquiring the Scheme Shares held by the Scheme Shareholders as of the Scheme Record Time, in consideration for which New Aptiv will issue, one ordinary share of $0.01 each (“New Aptiv Share”) to the Scheme Shareholders in exchange for each Scheme Share transferred.

68

Before the Court’s sanction can be sought for the Scheme, the Scheme requires approval by the Scheme Shareholders at the Court Meeting. The Scheme must be approved by (a) a majority in number of the Scheme Shareholders as of the Voting Record Time that are present and voting (in person or by proxy) and (b) at least 75% of the votes cast by the Company shareholders present and voting (in person or by proxy) at the Court Meeting. Approval of the Scheme is required for consummation of the transaction. For purposes of ensuring that there is more than one Scheme Shareholder of record, certain Company shareholders have effected transfers of some of their Company shares such that such shareholders directly hold a number of Company ordinary shares. The Scheme will also require, among other things, approval by the Company’s shareholders as of the Voting Record Time of the special resolutions being proposed at the Extraordinary General Meeting.

Subject to and conditional upon the Scheme becoming effective, on the terms of and subject to the conditions set forth in the Merger Agreement, Merger Sub will be merged with and into Aptiv, with Aptiv ceasing to exist and Merger Sub continuing as the surviving entity. Merger Sub will be named “Aptiv Swiss Holdings Limited,” will be a private company, and will be a direct, wholly owned subsidiary of New Aptiv. As a result of the Merger, the separate existence of Aptiv will cease at completion of the Merger, and all property, rights, privileges, powers and franchises of Aptiv will vest in Merger Sub at completion of the Merger, and all debts, liabilities and duties of Aptiv will become the debts, liabilities and duties of Merger Sub at completion of the Merger. It is currently expected that the Merger will complete shortly after the Effective Date.

The terms and conditions of the Merger are contained in the Merger Agreement, a copy of which is attached to this Proxy Statement as Annex C.

See “Part 1 – The Transaction and the Special Meetings—The Reorganization—Conditions to Consummation of the Transaction” beginning on page 38 for information regarding conditions to complete the transaction.

Date, Time, Place and Purpose of the Court Meeting

The Court Meeting is scheduled to be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210 on December 2, 2024 at 1:00 p.m. (Eastern time), for Scheme Shareholders on the register of members as of the Voting Record Time to consider and, if thought fit, approve the Scheme. As of October 31, 2024, there were 235,035,739 Company shares outstanding and entitled to vote at each of the Court Meeting and the Extraordinary General Meeting.

At the Court Meeting, voting will be by poll and each Scheme Shareholder present (in person or by proxy) will be entitled to one vote for each Scheme Share held as of the Voting Record Time. The Scheme must be approved by (a) a majority in number of those Scheme Shareholders as of the Voting Record Time that are present and voting (in person or by proxy) and (b) at least 75% of the votes cast by such Scheme Shareholders.

It is important that, for the Court Meeting in particular, as many votes as possible are cast, so that the Court may be satisfied that there is a fair and reasonable representation of opinion of the Scheme Shareholders. You are therefore strongly urged to sign and return your proxy for the Court Meeting as soon as possible. The completion and return of the forms of proxy will not prevent you as a Scheme Shareholder from attending, voting and speaking at either the Court Meeting or the Extraordinary General Meeting, or any adjournment or postponement thereof, in person if you are entitled to do so.

Notice of the Court Meeting is set out at the front of this Proxy Statement. Entitlement to vote at the meeting will be determined by reference to the register of members as of the Voting Record Time. For additional details, see “Part 1 – The Transaction and the Special Meetings—The Special Meetings of Company Shareholders—Voting Your Company Shares” and “Part 1 – The Transaction and the Special Meetings—The Special Meetings of Company Shareholders—Voting Company Shares Held in Street Name” each beginning on page 34.

69

Date, Time, Place and Purpose of the Extraordinary General Meeting

The Extraordinary General Meeting is scheduled to be held at Aptiv PLC’s offices at 100 Northern Ave, Boston Massachusetts 02210 on December 2, 2024 at 1:15 p.m. (Eastern time), or, if the Court Meeting has not concluded by 1:15 p.m. (Eastern time), as soon as possible after the conclusion of the Court Meeting, for Company shareholders on the register of members as of the Voting Record Time to consider and, if thought fit, approve the resolutions as fully set out in the notice of the Extraordinary General Meeting set out in the section titled “Notice of Extraordinary General Meeting of Aptiv PLC” (the “Resolutions”).

At the Extraordinary General Meeting, voting on the Resolutions will be by poll and each Company shareholder present (in person or by proxy) will be entitled to one vote for each Company share held as of the Voting Record Time. The approval required for Resolutions to be passed is at least two-thirds (2/3) of the votes validly cast in favor of such Resolution (in person or by proxy).

Notice of the Extraordinary General Meeting is set out at the front of this Proxy Statement. Entitlement to notice of and/or to vote at the meeting will be determined by reference to the Company’s register of members as of the Voting Record Time. For additional details, see “Part 1 – The Transaction and the Special Meetings—The Special Meetings of Company Shareholders—Voting Your Company Shares” and “Part 1 – The Transaction and the Special Meetings—The Special Meetings of Company Shareholders—Voting Company Shares Held in Street Name” each beginning on page 34.

Amendment to the Company’s Articles of Association

It is proposed, pursuant to Resolution #1, that the articles of association of Aptiv be amended to ensure that any Company shares issued under any share schemes or otherwise after the Voting Record Time in respect of the Court Meeting and on or prior to the Scheme Record Time will be subject to the Scheme. It is also proposed to amend the articles of association of Aptiv so that any Company shares issued to any person other than New Aptiv after the Scheme Record Time will be automatically acquired by New Aptiv on the same terms of the transaction (other than terms as to timings and formalities). These provisions will avoid any person (other than New Aptiv) being left with Company shares after the Scheme becomes effective.

Entitlement to Vote at the Court Meeting and Extraordinary General Meeting; Quorum

Each shareholder who is entered in the Company’s register of members as of the Voting Record Time will be entitled to attend and vote on all resolutions to be put to the Court Meeting and the Extraordinary General Meeting. If either meeting is adjourned or postponed, only those shareholders on the register of members two business days before the adjourned or postponed meeting will be entitled to attend and vote. Only beneficial owners of Company shares as of the Beneficial Holder Record Time will have the right to direct their broker, bank, trust or other nominee how to vote such Company shares. Shareholders of record do not need to register to attend the Special Meetings.

If your Company shares are held in “street name” by your broker, bank, trust or other nominee, only that holder can vote your Company shares and the vote cannot be cast unless you provide instructions to your broker, bank, trust or other nominee or you obtain a legal proxy from the registered holder of your shares. You should follow the directions provided by your broker, bank, trust or other nominee regarding how to instruct such person to vote your Company shares.

If you are a “street name” holder of Company shares in the Company, as a matter of Jersey law your name will not be entered in the Company’s register of members. Accordingly, if you wish to vote directly (i.e., in your own name) (in person or by proxy) at the Court meeting and/or the Extraordinary General Meeting, you must instruct your relevant broker bank, trust or other nominee to arrange for the transfer of the legal title to such Company shares to you prior to the Voting Record Time and at the same time you should also request forms of proxy for

70

use at the Court Meeting and the Extraordinary General Meeting whether or not you plan to attend those meetings. To register to attend the Extraordinary General Meeting and vote during the meeting, beneficial holders must request a legal proxy from their broker, bank, trust or other nominee. Requests for registration must be received no later than 5:00 p.m. (Eastern time) on November 22, 2024 in order to ensure timely registration.

The presence at the Court Meeting of two or more Scheme Shareholders on the register of members present (in person or by proxy) is necessary to constitute a quorum.

The presence at the Extraordinary General Meeting of a member or members present (in person or by proxy), who represent(s) at least the majority of the total voting rights of all the member or members entitled to attend and vote at the meeting is necessary to constitute a quorum. Abstentions and broker non-votes will be counted for the purpose of determining whether a quorum is present at the Extraordinary General Meeting.

Proxies

Holders of Company shares will receive a single mailing that will include a form of proxy that corresponds to the Court Meeting and a form of proxy that corresponds to the Extraordinary General Meeting. If you hold Company shares in your name as a shareholder of record, you should complete and return both forms of proxy accompanying this document to ensure that your vote is counted at both of the meetings, or at any adjournment or postponement of the meetings, regardless of whether you plan to attend the meetings. You may also authorize a proxy to vote your shares by telephone or over the internet as instructed on the applicable form of proxy.

If you hold your shares in “street name” through a broker, bank, trust or other nominee, you must direct your broker, bank, trust or other nominee how to vote in accordance with the instructions you have received from your broker, bank, trust or other nominee or obtain a legal proxy in your name from the registered holder of your shares.

If you are a shareholder of record of Company shares, you can revoke your proxy or voting instructions or change your vote after you have delivered your proxy or voting instructions in any of the following ways:

Aptiv PLC

5 Hanover Quay, Dublin 2, Ireland D02 VY79

Attention: Assistant Corporate Secretary; or

All Company shares represented by valid proxies that Aptiv received through this solicitation, and that are not revoked, will be voted in accordance with your instructions on the forms of proxy.

If you fail to make a specification on your form of proxy as to how you want your shares voted before signing and returning it, your proxy will be voted “FOR” the Scheme and “FOR” the Resolutions.

The Board is not currently aware of any business to be acted upon at the meetings other than the matters described in this Proxy Statement. If, however, other matters are properly brought before the meetings, the persons appointed as proxies will have discretion to vote or act on those matters as in their judgment is in the best interest of Aptiv and its shareholders.

71

Solicitation of Proxies

Aptiv PLC will pay the cost for soliciting proxies for the Special Meetings. Aptiv PLC will distribute proxy materials and follow-up reminders by mail and electronic means. We have engaged Innisfree M&A Incorporated (“Innisfree”) to assist with the solicitation of proxies. We expect to pay Innisfree an aggregate fee, including reasonable out-of-pocket expenses, of $45,000, depending on the level of services actually provided. Certain Aptiv PLC employees, officers and directors may also solicit proxies by mail, telephone or personal visits but they will not receive any additional compensation for their services.

Aptiv PLC will also reimburse brokers, banks and other nominees for their expenses in forwarding proxy materials to beneficial owners.

Under the Companies Law, the Scheme also requires the sanction of the Court. The hearing by the Court to sanction the Scheme is currently expected to be held on December 13, 2024, subject to the prior satisfaction or waiver of the other conditions set out in the section of this Proxy Statement titled “Part 1 – The Transaction and the Special Meetings—The Reorganization—Conditions to Consummation of the Transaction” beginning on page 38. Company Shareholders are entitled to attend and be heard at the Court Hearing, either in person or through a Jersey advocate, to support or oppose the Scheme. The address of the Court is Royal Court House, Royal Square, St Helier, Jersey JE1 1JG and its telephone number is +44 1534 441 300. The Company will disclose any change in the date of the Court Hearing by public announcement and SEC filing not less than 21 days before the Court Hearing.

Following sanction of the Scheme by the Court, the Scheme will become effective in accordance with its terms upon a copy of the Court order being delivered to the Registrar of Companies.

Upon the Scheme becoming effective, it will be binding on all Scheme Shareholders holding Scheme Shares at the Scheme Record Time (including Cede & Co. who holds Scheme Shares as a nominee and so, in effect, beneficial owners of shares), irrespective of whether or not they attended or voted in favor of, or against, the Scheme at the Court Meeting or in favor of, or against, or abstained from voting on the Resolutions at the Extraordinary General Meeting.

If the Scheme does not become effective by June 30, 2025 (or such later date permitted by the terms of the transaction agreement, as may be agreed in writing by Aptiv and New Aptiv and as the Court may approve (if such approval is required)), the Scheme will not become effective.

The Transaction is subject to a number of conditions which are summarized in the section captioned “Part 1 – The Transaction and the Special Meetings—The Reorganization—Conditions to Consummation of the Transaction” beginning on page 38.

Provided the conditions are satisfied or, to the extent applicable, waived, the Scheme will become effective upon delivery to the Registrar of Companies of a copy of the Court Order of the Court sanctioning the Scheme. Upon the Scheme becoming effective, it will be binding on all Scheme Shareholders, irrespective of whether or not they attended or voted at the Court Meeting or the Extraordinary General Meeting. It is expected that the Scheme will become effective and that Transaction will be completed in 2024.

Accompanying Documents for the Merger

In accordance with Article 127F of the Companies Law, this Proxy Statement is accompanied by the following attached hereto as Annex C:

72

Statement of Material Interests under Article 127F(2)(a)(v) of the Companies Law:

Aptiv PLC

The directors of Aptiv PLC and their share ownership are listed under “Security Ownership of Management and Directors.”

Following the consummation of the Transaction and immediately prior to the Merger, New Aptiv will be the sole shareholder of Aptiv PLC.

Aptiv Swiss Holdings

Two current Aptiv employees, who also serve as directors of various Aptiv subsidiaries, are directors of Aptiv Swiss Holdings.

New Aptiv is, and immediately prior to the Merger will be, the sole shareholder of Aptiv Swiss Holdings.

Upon the Scheme becoming effective, all of the Company’s directors intend to resign from the Board, and, following the subsequent Merger with Aptiv Swiss Holdings, the Company will cease to exist, with Aptiv Swiss Holdings continuing as the surviving entity. When the Reorganization is completed, the Company’s directors immediately prior to the completion of the Reorganization will be the directors of New Aptiv. The duration of the terms of office of the directors of New Aptiv, including the date on which they are next subject to reelection at an annual general meeting, will be the same as those applicable to them at that time in respect of their directorships of the Company.

Information in relation to existing and future indemnification and insurance arrangements to the Company’s current directors and executive officers is set out in paragraph 9 below.

This section describes the treatment of options and share awards in connection with the Scheme.

The Aptiv PLC Long-Term Incentive Plan provides for the granting of various forms of equity awards, including stock options, stock appreciation rights, restricted stock units and restricted stock. Aptiv PLC currently only grants restricted stock units pursuant to the Aptiv PLC Long-Term Incentive Plan and related award agreements that are both time-vesting and performance-vesting.

It is anticipated that in connection with the Transaction, New Aptiv will assume the Aptiv PLC Long-Term Incentive Plan, or make other arrangements for any outstanding awards under the Aptiv PLC Long-Term Incentive Plan to be settled in New Aptiv Shares. To the extent required, the Aptiv PLC Long-Term Incentive Plan will be amended, effective from the Transaction Time, to provide that all outstanding awards relating to

73

Company Shares will entitle the holder to purchase or receive, or receive benefits or amounts based on, as applicable, an equivalent number of New Aptiv Shares. All equity-based awards outstanding under the Aptiv PLC Long-Term Incentive Plan, which are currently restricted stock units, will otherwise generally be subject to the same terms and conditions as were applicable to such awards immediately prior to the Transaction Time. The rules of the Aptiv PLC Long-Term Incentive Plan and award agreement(s) will continue to apply.

At the Transaction Time, it is currently anticipated that the obligations of Aptiv PLC with respect to each of its employee benefit and/or compensation plans, severance plans, cash incentive plans, trusts, agreements, programs or arrangements will be assumed by New Aptiv and will be implemented and administered in the same manner and without interruption until the same are amended or otherwise lawfully altered or terminated.

In considering the recommendation of the Board, shareholders should be aware that no person who has been a director or executive officer of Aptiv at any time since the beginning of the last fiscal year, or any associate of any such person, has any substantial interest in the Reorganization, except for any interest arising from his or her ownership of securities of Aptiv. No such person is receiving any extra or special benefit not shared on a pro rata basis by all other holders of shares of Aptiv.

Details of the directors’ interests in Company shares are set out in the section titled “Part 1 – The Transaction and the Special Meetings—Security Ownership of Management and Directors” beginning on page 65. With regard to the Scheme, the directors will receive the same consideration as other Scheme Shareholders in relation to the Scheme Shares in which they are interested.

The Company’s Articles of Association require the Company, among other things and to the extent permitted by law, to indemnify the directors and executive officers against certain liabilities that may arise by reason of their status or service as directors or officers.

See the section entitled “Part 1 – The Transaction and the Special Meetings—The Reorganization—Interests of Certain Persons in the Reorganization” beginning on page 43.

The section entitled “Part 1 – The Transaction and the Special Meetings—Material Tax Considerations” beginning on page 47 sets forth the material tax consequences of the proposed transaction.

On the Effective Date, New Aptiv shall acquire all legal and beneficial title to all of the Scheme Shares, fully paid-up, free from all liens, equities, charges, encumbrances and other interests together with all rights at the Effective Date or thereafter attached thereto including without limitation the rights to receive and retain all dividends and other distributions (if any) announced, declared, made or paid in respect of the Scheme Shares.

For such purposes, the Scheme Shares shall be transferred to New Aptiv and such transfer shall be effected by means of a form of transfer or other instrument or instruction of transfer. Any person may be appointed by New Aptiv as attorney and/or agent and/or otherwise and shall be authorized as such attorney and/or agent and/or otherwise on behalf of the relevant holder of Scheme Shares to execute and deliver as transferor a form of transfer or other instrument or instruction of transfer (whether as a deed or otherwise) of such Scheme Shares in favor of New Aptiv and every form, instrument or instruction of transfer so executed shall be as effective as if it had been executed by the holder or holders of the Scheme Shares thereby transferred.

Following the consummation of the Scheme, all Company shares will be delisted from the NYSE and deregistered under the Exchange Act. The last day of dealings in the Company’s shares on the NYSE is currently expected to be on or about the Effective Date. No transfers of shares in the Company (other than transfers to New Aptiv) will be registered after the Scheme Record Time. At the effective time, any share certificates in respect of

74

the Company’s shares will cease to be valid and should, if so requested by the Company or its agents, be sent to the Company for cancellation.

New Aptiv will appoint the Exchange Agent to effect the technical implementation of the settlement of the Scheme consideration to Scheme Shareholders.

Consideration

Subject to the Scheme becoming effective, settlement of the consideration to which any Scheme Shareholder is entitled under the Transaction will be effected in the following manner:

Settlement

Settlement of the Scheme consideration shall be effected by the Exchange Agent who will perform all necessary steps in order to complete settlement and payment of the consideration under the Scheme. Upon proper surrender to the Exchange Agent of the share certificates or book-entry shares, together with a properly completed and validly executed letter of transmittal, the holder of such share certificates will be entitled to receive in exchange the Scheme consideration, to be delivered within ten business days following the later to occur of (x) the Effective Date or (y) the Exchange Agent’s receipt of such certificate or book-entry share. Alternatively, New Aptiv may appoint a person to sign and deliver a letter of transmittal or other instruction of transfer on behalf of the Scheme Shareholders to the Exchange Agent in accordance with the terms of the Scheme.

All deliveries of notices, certificates, statements of entitlement and/or cheques required to be made under the Scheme shall be made by or on behalf of the Exchange Agent as provided for or in connection with the transaction agreement, to the address appearing in the register of members of Aptiv at the Scheme Record Time or, in the case of joint holders, to the address of the holder whose name stands first in such register in respect of the joint holding concerned at such time.

None of Aptiv, New Aptiv or their respective agents or nominees shall be responsible for any loss or delay in the transmission of the statements of entitlement or cheques sent to Scheme Shareholders which shall be posted at the risk of the Scheme Shareholder concerned.

Certain Effects of the Scheme

At the completion of the Transaction, which is expected in 2024, Aptiv will become a wholly owned subsidiary of New Aptiv. New Aptiv shares issued to former Scheme Shareholders will rank equally in all respects with the existing New Aptiv shares and will be entitled to receive any dividends or other distributions declared or paid by New Aptiv in respect of New Aptiv shares with a record date on or after the date of their issue. Accordingly, former Scheme Shareholders will have an opportunity to vote and share in the future earnings, dividends or growth, if any, of New Aptiv.

75

This explanatory statement has been prepared for purposes of complying with the laws of Jersey, and the information disclosed may be different from that which would have been disclosed if this document had been prepared in accordance with the laws of jurisdictions outside Jersey.

As regards overseas shareholders of Aptiv based outside of Jersey (“Overseas Shareholders”), the Transaction may be affected by the laws of the relevant jurisdictions. Such Overseas Shareholders should inform themselves about and observe any applicable legal requirements. It is the responsibility of Overseas Shareholders to satisfy themselves as to the full observance of the laws of the relevant jurisdiction in connection therewith, including the obtaining of any governmental, exchange control or other consents which may be required, or the compliance with other necessary formalities which are required to be observed and the payment of any issue, transfer or other taxes due in such jurisdiction.

Overseas Shareholders are encouraged to consult their local tax and legal advisors.

See “Part 1 – The Transaction and the Special Meetings—The Special Meetings of Company Shareholders” beginning on page 31 for a summary of the actions to be taken.

The terms of the Scheme are set out in full in “Part 3 – The Scheme of Arrangement” of this Proxy Statement. Your attention is drawn to the conditions and further terms of the Transaction set out in the remaining parts of this document, all of which form part of this explanatory statement.

76

PART 3 – THE SCHEME OF ARRANGEMENT

77

THE SCHEME OF ARRANGEMENT

IN THE MATTER OF APTIV PLC

-AND-

IN THE MATTER OF THE COMPANIES (JERSEY) LAW 1991, AS AMENDED

SCHEME OF ARRANGEMENT

(under Article 125 of the Companies (Jersey) Law 1991, as amended)

between

APTIV PLC

and

THE HOLDERS OF THE SCHEME SHARES

(as defined below)

PRELIMINARY

78

79

and references to clauses or paragraphs are to clauses or paragraphs of this Scheme.

All references to “Dollars” and “$” are to the lawful currency of the United States of America.

All references to any statutory provision or law or to any order or regulation shall be construed as a reference to that provision, law, order or regulation as extended, modified, replaced or re-enacted from time to time and all statutory instruments, regulations and orders from time to time made thereunder or deriving validity therefrom.

Words importing the singular shall include the plural and vice versa, and words importing the masculine gender shall include the feminine or neutral gender.

A reference to “includes” shall mean “includes without limitation”, and references to “including” and any other similar term shall be interpreted accordingly.

80

THE SCHEME

one New Aptiv Share for every Scheme Share held at the Scheme Record Time (the “Exchange Ratio”).

81

With effect from and including the Effective Date:

All mandates relating to the payment of dividends on any Scheme Shares and other instructions (including communications preferences) given to the Company by Scheme Shareholders in force at the Scheme Record Time relating to Scheme Shares shall, as from the Effective Date, cease to be valid.

The Company and New Aptiv may jointly consent on behalf of all persons concerned to any modification of or addition to this Scheme or to any condition which the Court may think fit to approve or impose.

This Scheme is governed by Jersey law and is subject to the exclusive jurisdiction of the Jersey courts.

November 6, 2024

82

Annex A

New Aptiv

Memorandum and Articles of Association

A-1

Carey Olsen

47 Esplanade

St. Helier

Jersey

JE1 0BD

Channel Islands

A-2

COMPANIES (JERSEY) LAW 1991 (the “Law”)

MEMORANDUM OF ASSOCIATION

OF

APTIV PLC

(the “Company”)

a par value public limited company

Words and expressions contained in this Memorandum of Association have the same meanings as in the Law.

The name of the Company is Aptiv PLC.

The share capital of the Company is US$12,500,000 divided into 1,200,000,000 ordinary shares of US$0.01 each and 50,000,000 preferred shares of US$0.01 each (which may be issued in such class or classes as the Directors may determine in accordance with the Articles of Association of the Company).

The liability of a Member arising from the holding of a share in the Company is limited to the amount (if any) unpaid on it.

A-3

COMPANIES (JERSEY) LAW 1991

ARTICLES OF ASSOCIATION

OF

APTIV PLC

a par value public limited company

CONTENTS

A-4

A-5

COMPANIES (JERSEY) LAW 1991

ARTICLES OF ASSOCIATION

OF

APTIV HOLDINGS LIMITED

a par value public limited company

A-6

but a Member shall not be regarded as Present at a meeting unless the Member is entitled to attend and vote at that meeting;

A-7